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Summary 
 
An increasing number of human disorders are being linked to mutations in 
components of the secretory pathway. One example is combined blood coagulation 
factor V and VIII deficiency, an autosomal recessive disorder leading to hemophilia 
due to markedly reduced levels of coagulation factors V and VIII in blood plasma. 
This disorder is genetically linked to the transmembrane protein ERGIC-53 and its 
soluble luminal interaction partner MCFD2, both of which reside in the early secretory 
pathway. ERGIC-53 and MCFD2 constitute a transport receptor complex required for 
the efficient secretion of blood coagulation factors V and VIII. The strict dependence 
of some secretory proteins on receptor-mediated transport illustrates the need to 
understand this process in detail. 
The characterization of transport receptors and their cognate cargo proteins is 
hampered by the weak and transient nature of the underlying protein-protein 
interactions which take place in the rather specialized luminal environment of the 
endoplasmic reticulum (ER). As a matter of fact, many luminal protein interactions of 
secretory and membrane proteins are missed by standard techniques of interaction 
proteomics such as affinity isolation or the yeast-two hybrid system. To overcome 
these substantial technical limitations, we tested if a protein fragment 
complementation assay (PCA) based on the yellow fluorescent protein (YFP) can be 
applied in vivo to capture protein-protein interactions inside the lumen of the 
secretory pathway. YFP PCA relies on complementing YFP from two non-fluorescent 
fragments (YFP1 or YFP2) which have been fused to two test proteins. If the two test 
proteins interact, YFP1 and YFP2 are brought into close proximity which induces the 
correct folding and reconstitution of fluorescent YFP. By successfully applying a YFP 
PCA inside the lumen of the ER, we could visualize the interaction between ERGIC-
53 and its luminal interaction partners MCFD2, cathepsin Z and cathepsin C in a 
specific manner. Noteworthy, a direct interaction between cathepsin C and ERGIC-
53 has been suspected previously but could not be established by chemical 
crosslinking and affinity purification-based techniques. Thus, YFP PCA is a powerful 
tool to capture protein interactions inside the secretory pathway. 
To search for additional cargo proteins of ERGIC-53, we developed a novel 
genomewide fluorescence complementation-based cDNA library screen. For this 
purpose, we constructed for the first time a cDNA-YFP1 fusion library which meets all 
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the requirements for probing protein-protein interactions in the lumen of the secretory 
pathway by YFP PCA.  The library was co-transfected with the YFP2-ERGIC-53 bait 
into mammalian COS-1 cells. Fluorescence activated cell sorting was then used to 
isolate yellow fluorescent COS-1 cells from which library plasmids were recovered. In 
a small-scale pilot screen, we identified alpha-1-antitrypsin as potential interaction 
partner of ERGIC-53 suggesting that ERGIC-53 might bind more cargo proteins than 
initially assumed. The identification of alpha-1-antitrypsin demonstrates that YFP 
complementation can be successfully applied to screen a cDNA library for novel 
protein-protein interactions. This approach should provide a firm basis to map protein 
interactions inside the secretory pathway in a genomewide setting. 
With the ability to visualize and quantify protein interactions between ERGIC-
53 and its cargo in vivo, YFP PCA is a potent technique to analyze the ERGIC-
53/MCFD2 transport receptor complex in more detail. Hence, we used luminal YFP 
complementation to establish the cargo binding properties of the ERGIC-53/MCFD2 
complex and showed that ERGIC-53 can bind cathepsin Z and cathepsin C in a 
MCFD2-independent manner. This suggests cargo selectivity of the ERGIC-
53/MCFD2 complex. While ERGIC-53 can interact with cathepsin Z and cathepsin C 
in the absence of MCFD2, MCFD2 is selectively required for the recruitment of blood 
coagulation factors V and VIII. A combination of short interference RNA-mediated 
ERGIC-53 knockdown, immunofluorescence-based protein localization, and tracking 
of metabolically labeled MCFD2 revealed a strict dependence of MCFD2 on ERGIC-
53 for correct localization and intracellular retention. Our finding that MCFD2 is 
secreted upon a knockdown of ERGIC-53 explains the lack of MCFD2 that has been 
reported in ERGIC-53 deficient hemophilic patients suffering from combined blood 
coagulation factor V and VIII deficiency. 
In conclusion, this thesis provides deeper insight into receptor-mediated cargo 
capture by proposing cargo selectivity of the ERGIC-53/MCFD2 transport complex. 
Furthermore, the development of the luminal YFP PCA provides attractive and 
promising perspectives to analyze and screen protein interactions inside the lumen of 
the secretory pathway.  
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1. Introduction 
 
Endoplasmic reticulum Golgi intermediate compartment protein-53 (ERGIC-53) is a 
protein which has been intensively studied during the last 18 years1. Although 
ERGIC-53 has been characterized in detail, knowledge on its biological function as a 
cargo receptor is still incomplete. The lack of ERGIC-53 in humans causes reduced 
secretion of blood coagulation factors V and VIII2, 3. But why is ERGIC-53 
ubiquitously expressed at high levels while blood coagulation factor V and VIII 
expression is largely restricted to liver cells? Why is ERGIC-53 conserved in a 
species like C. elegans lacking a blood coagulation cascade? Are we missing an 
essential information about ERGIC-53? To address this point, I decided to search for 
further ERGIC-53 interaction partners which could give us insights into additional 
functions of the protein. 
Recently, a genetic screen reported the identification of multiple coagulation 
factor deficiency protein 2 (MCFD2) as luminal ERGIC-53 interacting protein4. Like 
ERGIC-53, MCFD2 is required for the secretion of blood coagulation factors V and 
VIII. Since the interaction between MCFD2 and ERGIC-53 strictly depends on the 
presence of calcium, this interaction has not been captured previously by a variety of 
ERGIC-53 pulldown approaches all of which lacked calcium. This raises the question 
if there is a better suited method for the identification of ERGIC-53 interaction 
partners than pulldown experiments. 
This thesis combines the area of protein secretion with the method-based field 
of interaction proteomics. The mammalian secretory pathway is introduced and 
molecular machineries which act in the lumen of the endoplasmic reticulum (ER) in 
processes such as protein folding, modification, quality control, degradation and 
secretion are described in detail. Furthermore, currently available techniques in 
interaction proteomics are presented and evaluated in regard of their application to 
capture ERGIC-53 interaction partners or luminal protein-protein interactions, in more 
general terms. The main focus lies on a  novel method called protein fragment 
complementation assay (PCA)5.  
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1.1 The secretory pathway of mammalian cells 
 
1.1.1 Organization of the secretory pathway 
The exchange of molecules between the intracellular and extracellular environment is 
an essential task for eukaryotic and prokaryotic cells. While small molecules such as 
ions pass cellular membranes through specialized channels, larger molecules such 
as proteins require more elaborate mechanisms to enter or leave a cell. Eukaryotic 
cells have developed a complex secretory pathway, composed of diverse membrane-
enclosed compartments to regulate the process of secretion (exocytosis) and protein 
uptake (endocytosis). Figure 1 depicts the mammalian endomembrane system which 
is responsible for transport and sorting of membrane and soluble proteins. The 
functional dissection of the secretory pathway began more than 30 years ago in the 
laboratory of George Palade with the visualization of the secretion process of tritium-
labeled proteins by electron microscopy autoradiography and subcellular 
fractionation. Newly synthesized secretory proteins were shown to be transported in 
a vectorial process from the ER via the Golgi apparatus to the plasma membrane6. 
 
 
 
Figure 1: Organization of the mammalian secretory pathway. 
The scheme illustrates the different compartments involved in exo- and endocytosis of proteins. The 
endoplasmic reticulum (ER), the ER Golgi intermediate compartment (ERGIC), the Golgi complex, the 
endosomal and lysosomal compartments as well as the plasma membrane are interconnected through 
vesicular transport pathways as indicated by arrows. The localization of coated membranes are 
depicted in blue for coat protein II (COPII), in red for coat protein I (COPI) and in orange for clathrin 
(Reproduced from Bonifacino and Glick, 20047). 
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The early secretory pathway is composed of the ER, the ER Golgi intermediate 
compartment (ERGIC) and the Golgi apparatus.  
 
ER 
The ER can be divided into three morphologically distinct subdomains, namely the 
nuclear envelope, the ribosome-covered rough ER and the ribosome-free smooth 
ER8. The rough ER is the entry point for secretory and membrane proteins into the 
secretory pathway and participates, together with the smooth ER, in lipid, cholesterol 
and steroid biosynthesis9 as well as cellular detoxification. The lumen of the ER 
provides a specialized environment assisting folding and modification of most 
proteins. Since the ER is the main controller of cellular protein folding and 
degradation, it is an important signaling organelle by regulating various cellular 
processes through the unfolded protein response (UPR)10.  
 
ERGIC 
The ERGIC consists of tubulovesicular membrane clusters located between the ER 
and the Golgi. The ERGIC is a stable compartment of long-lived stationary structures 
which are interconnected by highly mobile, short-lived elements11. The ERGIC is the 
first sorting station for anterograde cargo molecules. Secretory proteins are 
transported towards the Golgi while ER resident proteins are retrieved back to the 
ER12. Proteomic analysis of the ERGIC identified several chaperones suggesting an 
additional function of the ERGIC in post-ER protein quality control13.  
 
Golgi apparatus 
The Golgi apparatus consists of a series of flattened cisternal membranes which 
differ in their protein and lipid composition. During the secretion process, proteins 
enter the Golgi at the cis face and leave at the trans face while intra Golgi transport is 
thought to occur through either vesicular transport or cisternal maturation14. The 
Golgi apparatus is involved in cellular signaling, sphingolipid biosynthesis and is the 
major processing and sorting compartment15. Several Golgi resident enzymes are 
involved in the processing of N- and O-linked carbohydrate side chains. After 
completed posttranslational modification, proteins are sorted at the trans Golgi 
network (TGN) to their final destination such as plasma membrane, secretory 
granules, endosomes or lysosomes16.  
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1.1.2 The concept of vesicular transport 
The observation that newly synthesized secretory proteins can be detected during 
their secretion process within small vesicular carriers led to the fundamental principle 
of vesicular membrane transport6. Vesicles transport proteins and lipids between 
organelles by budding from a ‘donor’ compartment and fusing with an ‘acceptor’ 
compartment. Figure 2 illustrates the prevailing model of the budding and fusion 
machinery which ensures exchange of material between different organelles without 
affecting their homeostasis. To generate a vesicle, cytosolic coat proteins need to be 
recruited to the membrane and deform the lipid bilayer. To date, three different 
coatomers have been identified that participate in different intracellular transport 
pathways. The clathrin coat mediates vesicular budding from the Golgi, the plasma 
membrane and the endosomal compartments while coat protein I (COPI) and coat 
protein II (COPII) ensure bidirectional transport between the ER and the Golgi17.   
 
 
Figure 2: Vesicular budding and fusion machinery. 
(1) Coat assembly is initiated by the recruitment of coat proteins (blue) to membrane-associated 
GTPases (red). Transmembrane cargo and SNARE proteins are recruited into budding structures. (2) 
Outer coat components (green) bind to the budding complex, polymerize into a mesh-like network and 
induce vesicular formation. (3) Vesicular scission is caused by the coat itself or by accessory proteins 
at the neck between the vesicle and the donor compartment. (4) Vesicles are uncoated due to 
inactivation of membrane-associated GTPases, phosphoinositide hydrolysis or through the action of 
uncoating enzymes. Cytosolic coatomers are recycled for further rounds of vesicle budding while the 
uncoated vesicle moves towards the acceptor compartment. (5) Vesicles are tethered to the acceptor 
membrane through different Rabs and tethering factors. (6) v- and t-SNAREs interact with each other 
thereby promoting vesicle docking.  (7) Assembly of the SNAREs into a four-helix bundle induces 
membrane fusion (Reproduced from Bonifacino and Glick, 20047). 
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COPII-dependent trafficking from ER to Golgi is one of the best studied examples of 
vesicular transport and was primarily unraveled by two independent approaches:  
yeast genetics and vesicular transport in vitro. The laboratory of Randy Scheckman 
isolated several temperature-sensitive yeast mutants defective in protein secretion 
(so called sec mutants) thereby identifying many important components such as the 
Sec23, Sec24, Sec31 and Sec13 subunits of the COPII coat18. The laboratory of 
James Rothman set up an in vitro transport assay to analyze vesicular trafficking 
between mammalian Golgi cisternae19. Reconstitution of transport with recombinant 
proteins led to the identification of various proteins involved in vesicular budding and 
fusion.  
The generation of a COPII-coated vesicle starts with the conversion of the 
small GTPase Sar1 from the GDP- to its GTP-bound state. This GDP/GTP exchange 
is catalyzed by the ER resident, transmembrane protein Sec12 which acts as 
guanine exchange factor (GEF)20. Active, GTP-bound Sar1 exposes an amphipathic 
α-helix that facilitates the association with the ER membrane and primes membrane 
curvature21. While membrane-associated Sar1 recruits the Sec23-Sec24 heterodimer 
as inner layer of the COPII coat by directly interacting with the Sec23 subunit22, 
anterograde cargo molecules are recruited into the Sar1-Sec23-Sec24 pre-budding 
complex through a direct interaction between Sec24 and ER exit signals in the 
cytosolic tail of transmembrane proteins23-27. The pre-budding complex then recruits 
the Sec13-Sec31 heterotetramer as outer layer of the COPII coat, which polymerizes 
into a cage-like structure thereby driving vesicle formation and scission28. No 
accessory proteins have been identified for the scission process of COPII-coated 
vesicles. After scission, free COPII-coated transport carriers, recently visualized by 
immuno-electron tomography29, shed their coat and fuse with ERGIC membranes. 
Subsequently, anterograde vesicular carriers are transported to the Golgi apparatus 
in a microtubule and dynein/dynactin dependent process30, 31 and are tethered to the 
Golgi membrane trough tethering factors such as the oligomeric TRAPP I complex32 
or the coiled-coil protein p11533. Together with the ER Golgi SNARE proteins Bet1, 
Syntaxin5, membrin and Sec2234, 35, tethering factors guarantee specific fusion with 
the Golgi membrane. SNARE proteins not only specify but also drive the final 
membrane fusion step by assembling into a four-helix bundle thereby bringing the 
opposing membranes close enough to fuse36. After membrane fusion, the SNARE 
complex is untwisted and recycled through the action of α-SNAP and NSF37. 
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1.1.3 Protein folding and processing in the secretory pathway 
About one third of all newly synthesized proteins enter the secretory pathway for 
either secretion into extracellular space or sorting to their final intracellular residence. 
Co-translational translocation into the ER through the Sec61 pore complex 
represents the general mechanism for entering the secretory pathway38. The 
translocation event is preceded by the recognition of the N-terminal signal sequence 
in secretory and membrane proteins by the signal recognition particle (SRP)39. 
Binding to the SRP receptor targets the ribosome-nascent polypeptide-SRP complex 
to the Sec61 pore complex of the ER membrane40. Already during the translocation 
process newly synthesized proteins are modified and start to fold under the 
assistance of different ER resident enzymes. Disulfide bridge formation, N-
glycosylation, signal sequence cleavage and the attachment of glycosyl-
phosphatidylinositol (GPI) anchors belong to the major modification events occurring 
in the ER. Proper protein modifications are often a prerequisite for correct folding as 
exemplified by the tendency of glycoproteins to misfold and aggregate if glycosylation 
is inhibited41. An elaborate ER quality control system makes sure that only correctly 
folded proteins can leave the ER. Terminally misfolded proteins are re-translocated 
into the cytosol for degradation, a process known as ER-associated protein 
degradation (ERAD)42. The molecular machineries participating in folding, 
modification, ER quality control and ERAD will be described below in detail, and are 
summarized in Figure 3.  
 
Protein folding 
Protein folding in the ER is assisted by several general chaperones.  The most 
abundant and important chaperones are glucose regulated protein 78 (Grp78, also 
known as BiP) and glucose regulated protein 94 (Grp94) belonging to the Hsp70 and 
Hsp90 families of classical chaperones. Grp78 binds to hydrophobic sequences in 
many different proteins while Grp94 seems to limit its interactions to a small subset of 
substrates43, 44. Chaperones assist the folding process most likely by preventing off-
pathway folding intermediates thereby keeping the substrate in a folding-competent 
state. Grp78 and Grp94 can bind the same substrate by sequential interactions45. 
Recently it became evident that the classical ER chaperones form multiprotein 
complexes with other ER folding enzymes such as protein disulfide isomerase (PDI) 
which is involved in oxidative protein folding, or Cyclophilin B which belongs to the 
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cis/trans peptidyl prolyl isomerase (PPIase) family46, 47. A heterogeneous multiprotein 
network seems to cover the distinct requirements of protein folding in the ER48. In 
addition to general chaperones, there exist several protein-specific folding factors49. 
Hsp47 is an example of a collagen-specific binding protein acting as a molecular 
chaperon in the biosynthesis pathway of collagen50. 
 
Oxidative protein folding  
The formation of correct disulfide bonds is a requirement for many luminal proteins to 
gain their correct conformation. Inhibition of oxidative protein folding results in an 
accumulation of misfolded proteins in the ER and an activation of the UPR10. 
Oxidative protein folding is based on the oxidation, reduction and isomerization of 
disulfide bridges and is catalyzed by a family of proteins called oxidoreductases. 
Oxidoreductases are composed of thioredoxin-like catalytic domains containing a 
CXXC active site motif. PDI is the best characterized oxidoreductase and acts as a 
molecular chaperone as well as an isomerase in the folding process of substrate 
proteins51. The non-catalytic domain of PDI binds unfolded proteins through a 
hydrophobic binding pocket which allows the catalytic domain to interact with 
substrate molecules and rearrange disulphide bridges. The human oxidoreductase 
family consists of 14 PDI-like family members, many of which are still 
uncharacterized52.  
 
Signal sequence cleavage 
Proteins are targeted to the secretory pathway through a N-terminal signal sequence 
which is cleaved upon translocation into the ER in most instances. Signal sequence 
cleavage is performed by a signal peptidase complex composed of the five different 
membrane proteins SPC12, SPC18, SPC21, SPC22/23 and SPC25. SPC18 and 
SPC 21, the mammalian homologs of the essential yeast gene Sec11, contain 
catalytically active serine, histidine and aspartic acid residues and are considered to 
be proteolytic subunits of the signal peptidase complex53. In addition to the signal 
peptidase complex, a signal peptide peptidase was discovered which liberates and 
processes signal peptides by intramembrane cleavage54. 
 
N-linked glycosylation 
The addition and processing of N-linked glycans belongs to one of the major tasks of 
the ER55, 56. Glycoproteins contain a variety of structurally distinct N-linked 
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carbohydrate side chains which arise from the trimming and modification of a 14-
saccharide core glycan by diverse ER and Golgi resident glycosidases and 
glycosyltransferases57, 58. The 14-saccharide core glycan is co-translationally 
transferred from a dolicholpyrophosphate precursor to an asparagine residue in the 
Asn-X-Ser/Thr consensus sequence of a nascent glycoprotein. This reaction is 
catalyzed by the oligosaccharyltransferase (OST), an ER protein complex of nine 
integral membrane proteins, five of which are essential59. The different subunits 
attach OST to the Sec61 translocation pore, recruit dolicholpyrophosphate-
oligosaccharide precursors, scan nascent polypeptides for glycosylation motifs and 
catalyze finally the N-glycosylation reaction60. 
 
ER quality control  
N-glycans play an important role in ER quality control61. Depending on the structure 
of their N-glycans, glycoproteins can be retained in the ER or targeted for 
degradation. Already before termination of their synthesis, glycoproteins are trimmed 
by glucosidase I and II which remove the two outermost glucose residues. The 
resulting mono-glucosylated glycoproteins are bound and retained in the ER by 
calnexin and calreticulin. These two chaperone-like lectins interact with the thiol 
oxidoreductase ERp57 which catalyzes the rate-limiting step of protein folding in the 
ER, namely the formation of intramolecular disulfide bridges42. After release from 
calnexin and calreticulin, the remaining glucose residue is removed by glucosidase II 
and the folding state of the glycoproteins is monitored by UDP-glucose:glycoprotein 
glucosyltransferase (UGGT). UGGT recognizing both oligosaccharide and protein 
moieties62 and specifically reglucosylates incompletely folded glycoproteins which 
allows the reassociation with calnexin and calreticulin. Noteworthy, most 
glycoproteins can acquire their native structure in a single round of association with 
calnexin and calreticulin63. Correctly folded glycoproteins are not reglucosylated and 
can leave the ER. Apart from calnexin and calreticulin, several other ER enzymes 
such as Grp78, Grp94 or PDI participate in primary quality control by recognizing 
exposed hydrophobic regions or unpaired cystein residues and thereby retaining 
non-native proteins in the ER42, 49. 
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ER associated degradation 
Prolonged retention of a protein in the ER is an indication of its inability to gain the 
correct conformation. Terminally misfolded proteins need to be specifically 
recognized, retranslocated into the cytosol and degraded64. In yeast, the slow-acting 
ER mannosidase I temporally controls the retention time of glycoproteins in the ER 
and initiates the ERAD process by trimming glycans to their Man8GlcNAc2 B 
isoform65, 66. This B isoform is specifically recognized by the luminal lectins Htm1p 
and Yos9p. Interestingly, Yos9p can be found in a luminal complex containing Kar2p, 
the homologue of mammalian Grp7867. Kar2p is thought to prevent aggregation of 
misfolded proteins by maintaining them in a retranslocation-competent conformation. 
In mammalian cells, ERAD is also initiated by mannose trimming. Glycoproteins are 
however trimmed down to Man5-6GlcNAc268 and are bound by ER-degradation 
enhancing α-mannosidase-like proteins 1-3 (EDEM1-3)69, 70. Noteworthy, EDEM1 is 
the mammalian homologue of yeast Htm1p. Binding of Htm1p and Yos9p in yeast or 
EDEM1-3 in mammalian cells is believed to target misfolded proteins for 
retranslocation into the cytosol.  How exactly and through which channel the process 
of retranslocation occurs is still a matter of debate71. In the cytosol, proteins are 
completely deglucosylated and targeted via ubiquitination for 26S proteasomal 
degradation.  
 
GPI anchoring  
GPI anchoring is a covalent, post-translational protein modification attaching diverse 
enzymes, receptors and antigens to the membrane via their carboxy-terminus. GPI is 
synthesized in a multi-step reaction in the ER and is composed of oligosaccharides 
as well as inositol phospholipids. A carboxy-terminal, hydrophobic signal marks 
proteins for GPI anchoring. The addition of GPI is catalyzed by an ER transamidase 
complex, consisting of at least five protein subunits. The transamidase complex 
recognizes and cleaves the GPI-anchoring hydrophobic signal before covalently 
linking GPI72.   
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Figure 3: ER folding, modification, quality control and degradation machinery. 
Proteins entering the secretory pathway are co-translationally inserted through the Sec61 pore 
complex into the ER. In the lumen of the ER, proteins are processed by an elaborate folding and 
modification machinery (green). Oxidoreductases and folding enzymes are thought to participate 
actively in the folding process while chaperons keep the substrate in a folding-competent conformation 
by preventing aggregation. ER resident enzymes such as oligosaccharyltransferase (OST), 
glucosidase I and II, signal peptidase or the transamidase complex modify the folding substrates. The 
folding and modification process is monitored by an ER quality control machinery (red). General 
chaperones and oxidoreductases participate in primary quality control by retaining proteins with 
exposed hydrophobic regions or unpaired cystein residues in the ER. Calnexin, calreticulin, ERp57, 
glucosidase II and UDP-glucose:glycoprotein glucosyltransferase (UGGT) compose the calnexin-
calreticulin cycle retaining glycoproteins in the ER and promote correct folding. While correctly folded 
proteins can leave the ER in COPII-coated vesicles, terminally misfolded proteins are recognized and 
degraded by the ER-associated protein degradation (ERAD) machinery (blue). Misfolded luminal 
proteins are processed by the slow acting ER mannosidase I, recognized by lectins such as Yos9p or 
ER-degradation enhancing α-mannosidase-like proteins 1-3 (EDEM1-3) and retranslocated into the 
cytosol for degradation. General chaperons and oxidoreductases participate in the ERAD process as 
well. The different players of the folding, modification, quality control and ERAD machinery are thought 
to compose a network of flexible, heterogeneous multiprotein complexes interacting with the 
substrates to be processed.  
Introduction 16 
 
1.1.4 Protein exit from the ER 
 
ER exit of transmembrane proteins 
Transport competent proteins leave the ER in COPII-coated vesicles. 
Transmembrane proteins can be selectively incorporated into budding vesicles by 
direct interaction between their cytosolic tails and the Sec24 subunit of the COPII 
coat73. The interaction with Sec24 is mediated by different conserved amino acid 
motives, termed ER exits signals. Studies on the vesicular stomatitis virus 
glycoprotein (VSV-G) led to the identification of the di-acidic (DXE) export motif74. ER 
export of the potassium channel Kir2.1 and the yeast proteins Gap1p and Sys1p also 
relies on di-acidic export signals75-77. The characterization of ERGIC-53 targeting 
determinants led to the identification of the di-hydrophobic motives as additional 
class of ER export signals78. The di-phenylalanine motif in ERGIC-53 can be 
substituted by a single phenylalanine or tyrosine at position -2, two leucines or 
isoleucines at position -1 and -2 or a single valine at position -1. Importantly, the 
single carboxy-terminal valine can be transplanted to other membrane proteins and 
accelerate their transport, hence acting as a true ER export signal23. The finding that 
ERGIC-53 hexamerization is required for efficient ER exit suggests that the 
oligomeric presentation of di-hydrophobic motives enhances the recruitment into 
COPII-coated vesicles79, 80. In addition to ERGIC-53, di-hydrophobic ER exit motives 
can be found in transmembrane proteins belonging to the p24 family of proteins or 
the Erv41-Erv46 complex81, 82. A third class of ER export signals, the di-basic (R/K-X-
R/K) motives, was discovered in Golgi glycosyltransferases. In contrast to the di-
acidic and di-hydrophobic signals, di-basic motives interact with the Sar1 component 
of the COPII coat27. How can the COPII coat recruit at least three different ER export 
signals? The participation of Sec23, Sec24 as well as Sar1 in the cargo binding 
process is for sure one option. In addition, coat proteins might accommodate different 
cargo proteins by having multiple binding sites. In Sec24 three different binding sites 
can bind the di-acidic export motif as well as signals in the ER Golgi SNARE proteins 
Sed5, Bet1 and Sec2224, 25. Another intriguing finding is that the different isoforms of 
Sec24, four of which can be found in humans, show selective binding preferences for 
different ER exit signals (unpublished data, M.Wendeler). 
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ER exit of soluble proteins 
In contrast to transmembrane proteins, soluble luminal proteins can not directly 
interact with the cytosolic COPII coat. Soluble proteins were first proposed to enter 
budding vesicles at their prevailing luminal concentration, a model based on bulk 
flow-mediated transport83. The bulk flow model was challenged by the finding that 
certain soluble cargo proteins are enriched in COPII-coated vesicles. Glycosylated 
pro-α-factor, for example, was enriched about 20 fold in ER-derived vesicles in 
comparison to the ER. This enrichment is dependent on the membrane protein 
Erv29p which suggests receptor-mediated cargo capture for ER exit76. The concept 
of receptor-mediated ER export was strengthened by the recent identification of a 
hydrophobic signal in glycosylated pro-α-factor which is required for binding to 
Erv29p and for its efficient packaging into COPII-coated vesicles. Importantly, this 
hydrophobic signal can be transplanted to the ER resident protein Kar2p thereby 
promoting its incorporation into COPII-coated vesicles84. So far, Erv29p is the best 
characterized cargo receptor in yeast and specifically recruits not only glycosylated 
pro-α-factor but also vacuolar hydrolases, carboxypeptidase Y and proteinase A85. 
There is also evidence for receptor-mediated ER export of soluble cargo 
proteins in mammalian cells. The transmembrane protein ERGIC-53 captures soluble 
proteins such as cathepsin Z, cathepsin C and blood coagulation factors V and VIII in 
the ER and displays many characteristics of a cargo receptor3, 86-89. The di-
phenylalanine motif in the cytosolic tail of ERGIC-53 binds to COPII which ensures 
the recruitment  into ER-derived vesicles for anterograde transport78.  Furthermore, a 
di-lysine motif that interacts with COPI mediates retrieval back to the ER90. Binding to 
COPII as well as COPI enables ERGIC-53 to cycle between the ER and the ERGIC. 
ERGIC-53 is a mannose-binding lectin86, 91 and a histidine residue in its 
carbohydrate recognition domain modulates the lectin activity in a calcium- and 
pH-dependent manner. This raises the possibility that calcium and pH control 
cargo binding and release in different compartments. Loss-of-function mutations 
in ERGIC-53 lead to combined blood coagulation factor V and VIII deficiency in 
humans (OMIM # 227’300)3. These patients show reduced levels of blood 
coagulation factors V and VIII in the plasma. A reduced secretion of blood 
coagulation factors V and VIII was also shown in mammalian cell cultures upon 
expression of a cycling deficient ERGIC-53 mutant2. Interestingly, the efficient 
secretion of blood coagulation factors V and VIII requires an additional protein, 
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named MCFD24. MCFD2 is a soluble, luminal protein which interacts with ERGIC-53 
in a calcium-dependent manner. The participation of ERGIC-53 as well as MCFD2 in 
the secretion process of blood coagulation factors V and VIII raises the intriguing 
possibility of cargo receptor complexes composed of a transmembrane and a soluble 
protein. 
The existence of receptor-mediated ER export of luminal proteins has been 
documented in yeast as well as mammalian cells86, 92. The prevalence of receptor-
mediated ER exit, however, remains elusive. Receptor-mediated ER export may 
account for only a subset of soluble proteins while the majority of proteins might rely 
on bulk flow-mediated transport (Figure 4). Perhaps only rare soluble proteins require 
a receptor for efficient recruitment into COPII-coated vesicles. Moreover, cargo 
receptors might act as secondary quality control by capturing only correctly folded 
cargo proteins.  
 
 
 
Figure 4: Bulk flow- and receptor-
mediated ER export of soluble proteins. 
The bulk flow model predicts that abundant 
soluble proteins (blue) enter COPII-coated 
vesicles (red) at their prevailing luminal 
concentration. Transmembrane receptors 
(gray) are recruited into budding vesicles by 
direct interaction between their cytosolic tail 
and the COPII coat. The transmembrane 
receptors bind luminal cargo proteins 
(orange) thereby recruiting them into 
vesicles. Receptor-mediated ER export 
could enrich rare soluble proteins inside ER-
derived vesicles and function as secondary 
quality control process. 
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1.2 Interaction proteomics 
 
In 2001, a first draft of the human genome was released93. Three years later most 
gaps in the human genome were closed and the number of protein-coding genes 
was estimated to be in the range of 20’000-25’00094. What is the biological function 
of all these proteins in a human cell? This challenging question is currently tackled 
amongst others by interaction proteomics. According to the concept of ‘guilt-by-
association’, proteins that interact with one another fulfill similar biological functions95, 
96. The analysis of protein interaction networks in yeast demonstrated that most 
biological processes require protein complexes rather than single proteins97. The 
dissection of multiprotein complexes and the identification of all interacting proteins 
are therefore crucial to assess the biological function of the many currently 
uncharacterized proteins. Given that the estimated 5 interaction partners per yeast 
protein98 are also true for higher eukaryotes, we are left with at least 100’000 protein 
interactions per human cell. How can we analyze this plethora of interactions and 
how can we characterize the different properties of protein interactions as depicted in 
Figure 5? 
 
 
Figure 5: The different levels of characterization of protein complexes. 
The detailed analysis of a protein complex requires the identification of interacting proteins as well as 
the determination of structure, oligomeric state, stoichiometry and cellular localization of the complex. 
Furthermore, the kinetics and affinities of the individual interactions have to be determined and the 
amino acid residues making contact at the interaction interface need to be identified. 
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Interaction proteomics has been greatly facilitated by the availability of genome 
sequence data and versatile methods for the analysis of protein-protein 
interactions99-101. In order to identify protein interaction partners, methodologies are 
available for screening large numbers of different protein interactions. Typically, a 
protein of interest (called ‘bait’) is used to screen for novel interacting proteins (called 
‘preys’). Affinity purification of multiprotein complexes, protein microarrays and 
library-based screening methods such as the yeast-two hybrid system belong to the 
currently most popular methods in interaction proteomics and are described in more 
detail on pages 22-28. The emerging field of computational-based prediction of 
protein-protein interactions and its application to the construction of protein 
interaction networks is presented on page 29. Once interaction partners are 
identified, the biochemical and biophysical properties of the underlying protein 
interactions can be characterized by a number of sophisticated methods (Table 1).  
 
 
Table 1: Commonly used methods for the characterization of protein complexes 
 
Determination of kinetics and affinities of protein-protein interactions 
 
- surface plasmon resonance 
- affinity chromatography 
- isothermal titration calorimetry  
 
Analysis of protein-protein interaction interfaces 
 
- nuclear magnetic resonance spectroscopy  
- hydroxyl-radical footprinting  
- reverse yeast two-hybrid  
  
Determination of the oligomeric state and structure of protein complexes 
 
- gel filtration  
- analytical ultracentrifugation  
- light scattering 
- electron microscopy  
- X-ray crystallography  
- nuclear magnetic resonance spectroscopy  
- atomic force microscopy  
 
Analysis of cellular localization and dynamics of protein complexes 
 
- fluorescence resonance energy transfer  
- protein fragment complementation  
- single-molecule spectroscopy  
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1.2.1 Affinity purification-based techniques 
One of the most elaborate and broadly applied methods to identify interacting 
proteins combines affinity-based isolation of protein complexes and mass 
spectrometry-based protein identification (Figure 6).  
Ideally, an endogenous protein is purified with associated proteins from its 
physiological context using a specific antibody. Since the number of specific 
antibodies is limited, a more general strategy is to purify a tagged version of the 
protein. Glutathione S-transferase, small peptide epitopes like FLAG, HA or c-myc as 
well as poly-His tails can serve as affinity tags for protein isolation using immobilized 
glutathione, anti-epitope antibodies or nickel ions. Recently, a tandem affinity 
purification (TAP) tag was introduced which allows two sequential affinity isolation 
steps thereby increasing the specificity of the isolation procedure under largely 
physiological conditions102. 
 
 
 
Figure 6: Affinity purification-based identification of protein interaction partners. 
A protein of interest is fused to an affinity tag as exemplified by the HA epitope. (1) The HA-tagged 
protein is expressed and associates with endogenous interaction partners. (2) The protein complex is 
isolated using anti-HA immunoprecipitation. (3) Unbound proteins are washed away and the protein of 
interest is eluted with its associated partners and fractionated by SDS-PAGE. (4) Separated proteins 
are excised, digested with a sequence-specific protease such as trypsin and identified by mass 
spectrometry. 
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After immobilizing the endogenous or affinity tagged protein of interest, unbound 
proteins are removed in distinct washing steps and interacting proteins are eluted, 
separated by SDS-PAGE and identified by mass spectrometry procedures. 
Electrospray ionization and matrix-assisted laser desorption/ionization belong to the 
most commonly used techniques to volatize proteins while ion trap, time-of-flight, 
quadrupole and Fourier transform ion cyclotrons belong to the most commonly used 
analyzers for mass measurement103.  
Affinity purification-based methods have the advantage of capturing interaction 
partners expressed in their native sub-cellular location. Protein complexes composed 
of multiple interaction partners including soluble and membrane proteins can be 
dissected. In order to co-isolate interacting proteins, one has to find suitable 
conditions and buffers allowing the protein interactions to be maintained in vitro after 
cell lysis. Amount and nature of the detergent, salt concentrations as well as the 
addition of certain cofactors need to be adjusted for different protein interactions. 
Despite the need of adjusting conditions for different protein interactions, affinity 
purification-based methods were successfully applied in two large-scale studies. The 
protein-protein interaction network of S. cerevisiae was partially mapped upon affinity 
isolation of either TAP-tagged104 or FLAG-tagged105 yeast proteins followed by the 
identification of co-isolated proteins by mass-spectrometry.  Noteworthy, these two 
large-scale studies, although internally reproducible, showed little overlap which 
suggests non-saturating screening conditions in terms of covering only subsets of all 
possible protein-protein interactions106.  
 
1.2.2 Protein array-based techniques 
Protein array-based techniques probe proteins immobilized in a spatially resolved 
manner on a solid support, with a molecule of interest (Figure 7). Protein arrays 
consist of either crude protein extracts or purified, recombinant proteins, spotted on 
filter membranes or solid surfaces like glass slides.  
Far-Western-based screening of high-density protein filters has been 
successfully applied for the identification of protein interaction partners107. High-
density protein filters contain arrayed crude protein extracts from individual bacterial 
clones expressing recombinant proteins from a cDNA library. These filters are probed 
with the protein of interest which is consequently visualized by Western blotting. The 
positional information of the Western blot signal allows the identification of the 
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bacterial clone harboring the cDNA plasmid responsible for the expression of the 
interaction partner108. In addition to Western blot-based detection, high-density 
protein expression filters can be directly probed with a radiolabeled protein of 
interest109.  
By developing the immobilization of large number of different proteins on solid 
surfaces in a functional manner, the first protein microarray experiments were made 
possible110, 111. In 2001, a protein microarray containing the whole yeast proteome 
was produced by spotting 5800 purified, poly-His tagged yeast proteins onto nickel 
coated slides. Several calmodulin- and phospholipid-binding proteins were identified 
by probing the protein microarray with biotinylated calmodulin and liposomes 
followed by the visualization with fluorescent-labeled streptavidin112.  The application 
of microarrays to protein interactions in the human proteome is so far restricted to the 
analysis of protein interaction domains. An interaction network of the human 
epidermal growth factor receptors was recently created by measuring the affinities 
between different SRC homology 2 and phosphotyrosine binding domains113.  
 
 
 
Figure 7: Protein microarray technology. 
Individual proteins are purified and immobilized in a functional manner in high density on a solid 
surface to form a protein microarray. A protein of interest is added to the microarray and interacts in 
vitro with its interaction partners. Visualization of the protein of interest identifies interacting proteins 
on the microarray.  
 
Array-based techniques have the potential to unravel interaction networks rapidly 
because once the array is prepared a large number of interactions can be probed at 
the same time. The possibility to analyze protein-protein, protein-lipid, protein-
carbohydrate as well as protein-drug interactions is a key advantage of the 
technology114. The limiting factor of protein microarrays is the need to generate 
purified, recombinant proteins for spotting.  Given the 20’000-25’000 protein coding 
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human genes, this is associated with a tremendous amount of work. The successful 
identification of protein interaction partners in microarray-based experiments relies 
again on finding the right in vitro conditions allowing the interactions to take place. 
Since spotted onto one array, a single condition has to be chosen for all protein 
interactions leaving no possibility for individual optimization.  
 
1.2.3 Library-based techniques 
Library-based methods probe protein interactions between a bait and a library-
encoded prey protein. The complexity of the library determines the number of binary 
protein interactions to be screened. Ideally, a library expresses a representative of 
each protein in the proteome99. Versatile techniques like phage display, the yeast 
two-hybrid system or protein fragment complementation assays use a library-based 
approach to identify protein interaction pairs. 
 
Phage Display 
The phage display technique is based on the insertion of a DNA sequence library into 
the genome of a filamentous phage such as M13. Since the DNA sequences are 
inserted into a coat protein of the phage, fusion proteins are expressed and displayed 
on the phage surface. An immobilized protein of interest is used to capture phages 
displaying interaction partners on their surface while non-binding phages are washed 
away. Protein interactions are detected in vitro. In successive rounds of selection 
(called biopanning) specific phages are enriched and thereafter characterized115. The 
use of complex libraries in combination with an enrichment strategy is a major 
advantage of the phage display technology. Serious limitations derive from the 
limited folding and modification capacity of filamentous phages. In addition, 
analyzable proteins are restricted in size and chemical properties since they need to 
be able to cross the phage lipid bilayer for being displayed on the extracellular 
surface. Transmembrane interaction partners and proteins larger than 90 kDa have 
never been identified by phage display-based screening presumably due to their 
inability to pass the outer phage membrane116.  
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Yeast two-hybrid system 
The invention of the yeast two-hybrid system launched the possibility to identify 
protein-protein interactions in vivo117. This technique takes advantage of yeast cells 
and the modular architecture of transcription factors as a screening tool. The DNA-
binding domain (DBD) and the transcription activation domain (TAD) of a 
transcription factor are divided and fused to two separate proteins. If the two proteins 
interact, DBD and TAD can be brought into close proximity thereby reconstituting a 
functional transcription factor which activates reporter gene expression in yeast cells 
(Figure 8). Commonly used reporter genes are lacZ for color selection and 
auxotrophic genes such as LEU2, HIS3 or ADE2 for growth selection. To identify 
interaction partners, a protein of interest (bait) is usually fused to the DBD and 
screened against a cDNA library (prey) fused to the TAD. Under the appropriate 
selection conditions only yeast cells expressing interacting bait and prey proteins will 
grow. The yeast two-hybrid technology requires no protein purification steps and 
detects protein interactions in the living cell. This allows the detection of weak and 
transient protein interactions with even low stoichiometry interaction partners. 
 
Figure 8: The yeast two-hybrid 
system. A bait protein, fused to the 
DBD is co-expressed with a library of 
prey proteins, fused to the TAD. If 
the bait interacts with a prey protein, 
DBD and TAD can reconstitute a 
functional transcription factor and 
activate the expression of a reporter 
gene. Activation of the reporter gene 
will promote cellular growth under 
the appropriate selection conditions. 
If bait and prey protein fail to interact 
with each other, the reporter gene 
will not be transcribed and yeast 
cells will fail to grow in selective 
medium. 
 
The power of the yeast two-hybrid system has been demonstrated by several 
genome-wide screens for the proteomes of S. cerevisiae118, 119, C. elegans120 and 
Drosophila melanogaster121. A preliminary map of the human proteome was also 
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published on the basis of the yeast-two hybrid technique122. To cover as many 
human protein interactions as possible, different libraries have to be generated from 
various tissues and developmental stages. Disadvantages of the yeast two-hybrid 
system are the identification of many false positive interactions and its restriction to 
soluble proteins118, 123. Furthermore, protein interactions taking place in specialized 
subcellular compartments might not be revealed by the yeast two-hybrid system 
since probed in a nuclear environment. During the last decade, many variations of 
the classical yeast two-hybrid system have been reported124, 125. 
 
Protein fragment complementation assays 
One variation of the classical yeast two-hybrid system takes advantage of the small 
protein ubiquitin. Test proteins are tagged with either the N-terminal fragment of 
ubiquitin or the C-terminal fragment of ubiquitin to which a transcription factor is 
fused. The interaction of the test proteins brings the two fragments of ubiquitin into 
close proximity reconstituting split-ubiquitin, which is readily recognized and cleaved 
by ubiquitin-specific proteases in the yeast cytosol126. Since ubiquitin-specific 
proteases cleave at the C-terminus of ubiquitin they release the transcription factor 
fused to the C-terminal fragment. The released transcription factor can translocate 
into the nucleus and activate the expression of a reporter gene. The split-ubiquitin 
technology is particularly useful for the analysis of protein interactions with integral 
membrane proteins since the protein interaction event and its subsequent detection 
are spatially separated127, 128. The split-ubiquitin system is illustrative for the 
technological development from the classical yeast two-hybrid system towards more 
general applicable protein fragment complementation assays (PCA). The detection of 
protein-protein interactions by PCA relies on the reconstitution of the reporter protein 
itself from two rationally dissected fragments (Figure 9). This is in contrast to the 
yeast two-hybrid and split-ubiquitin technology where protein interactions are 
detected indirectly through the transcriptional activation of reporter genes.  The direct 
detection of the reconstituted reporter allows the PCA to visualize protein interactions 
in almost every sub-cellular compartment and cell type. Protein fragment 
complementation has been applied successfully to several reporter proteins such as 
β-lactamase, dihydrofolate reductase, Renilla and firefly luciferase as well as different 
fluorescent proteins129-134. All of these reporter proteins can be reconstituted from two 
fragments which are brought into close proximity through the interaction of two test 
proteins.  
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Figure 9: The basic concept of PCA.  
A reporter protein is rationally dissected into fragments 1 (light grey) and 2 (dark grey) which are fused 
to two test proteins (red and blue). The PCA reporter fragments alone show no reporter activity. Upon 
interaction of the two test proteins, fragments 1 and 2 are brought into close proximity and can 
reconstitute the PCA reporter by folding into an active conformation. PCA reporter activity can be 
detected using assays based on cell survival (for DHFR), luminescence (for Renilla and firefly 
luciferase) or fluorescence (for fluorescent proteins). 
 
Protein fragment complementation of fluorescent proteins is also known as 
bimolecular fluorescence complementation (BiFC) and has gained broad interest in 
different areas of biology. Fluorescence complementation is an especially attractive 
approach since fluorescent proteins are known to express, fold and fluoresce in 
almost every cell type and subcellular compartment135. Protein interactions have 
been visualized between soluble133 as well as membrane proteins136 and in different 
species such as bacteria, fungi, plants and mammalian cells137. By testing a library of 
antiparallel leucine zippers in bacteria, fluorescence complementation was shown to 
trap even weak and transient interactions with a minimal strength (KD) of 1mM135. 
Fluorescence complementation is a powerful method to study enzyme-substrate 
complexes138, to localize protein complexes133, to investigate signal transduction 
cascades139 and can be used to identify protein interaction partners using a library-
based approach140. In 2004, the first genomewide fluorescence complementation-
based cDNA library screen successfully identified an interaction partner of protein 
kinase PKB/Akt. In this screen, a human brain cDNA library was tagged with 
fragment 1 of GFP and PKB/Akt, fused to fragment 2 of GFP, was used as a bait. 
Bait and prey proteins were co-expressed in mammalian COS cells which were 
subsequently subjected to fluorescence activated cell sorting (FACS). The Ft1 
protein was identified as PKB/Akt interacting protein after isolation and sequencing of 
prey plasmids from GFP positive COS cells141. 
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1.2.4 Computational-based techniques 
Apart from experimental techniques various computational-based methods have 
been developed to analyze protein-protein interactions. Presence or absence of 
genes in related species, conservation of gene neighborhood, gene fusion events, 
correlated mutations or similarity of physiological trees were successfully applied in 
the prediction of protein interactions142. With the availability of experimental high-
throughput datasets recent attempts in bioinformatics tend to integrate several 
datasets for the prediction of protein interaction networks143. High-throughput 
interaction datasets from model organisms like S. cerevisiae104, 105, 118, 119, C. 
elegans120 or Drosophila melanogaster121 are combined with mRNA expression 
profiles, protein localization data, information regarding protein interaction domains or 
functional annotations. These often incomplete datasets are integrated using 
Bayesian statistics144 leading to quite robust protein interaction networks. By this 
means, a first map of the human protein-protein interaction network was modeled 
that predicts about 40’000 protein interactions145.  
To store, categorize and analyze the growing number of protein interactions 
several databases have been compiled. The Human Protein Interaction Database 
(HPID, http://www.hpid.org)146 or the Yeast Protein Database (YPD: 
http://www.biobase-international.com)147 are examples of organism specific protein 
interaction databases. In turn, the Database of Interacting Proteins (DIP: 
http://dip.doe-mbi.ucla.edu)148 contains data from different species but is restricted to 
solely experimentally determined protein-protein interactions. The majority of all 
protein-protein interactions that can be found in the DIP have been identified by the 
yeast two-hybrid screening system (52%) and co-immunoprecipitation of interacting 
proteins (18%)148. 
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1.3 Identification of protein-protein interactions in the 
lumen of the secretory pathway 
 
Which current technique in interaction proteomics is best suited to identify protein-
protein interactions in the lumen of the secretory pathway? Luminal protein 
interactions take place in the rather specialized environment of the ER. The ER 
milieu differs from the cytosol in respect to redox potential, ion concentrations as well 
as the presence of a specialized folding machinery. The lumen of the ER is 20 to 100 
times more oxidizing than the cytosol149 and with 20-200μM the concentration of free 
calcium is at least 200 times higher than in the cytosol150. Furthermore, the ER is 
densely packed with chaperones and modifying enzymes thereby highly 
outnumbering the substrates to be folded and modified151. The folding and 
modification process in the ER requires many transient protein-protein interactions as 
exemplified by newly synthesized proteins that bind to various chaperones during 
their folding process. Many luminal protein interactions are not only transient but also 
of low-affinity as exemplified by the many carbohydrate-mediated interactions 
between glycoproteins and ER lectins operating in protein secretion and quality 
control. Due to their transient and weak nature, luminal protein-protein interactions 
are difficult to capture. A further challenge is that many luminal protein interactions 
involve integral membrane proteins. Thus, identification of luminal protein-protein 
interactions requires a method that captures weak and transient protein interactions 
between soluble as well as integral membrane proteins, preferentially under oxidizing 
conditions and high calcium levels.  
 
Affinity purification 
Mass spectrometry-based characterization of affinity purified protein complexes can 
be applied to identify novel, luminal protein-protein interactions as recently 
demonstrated for the Yos9p-Kar2p-Hrd3p complex involved in ER associated protein 
degradation67, 152. Many luminal protein interactions are not revealed, however, since 
affinity purification requires a protein isolation step which mainly preserves stable 
interactions. Chemical crosslinking with thiol-cleavable crosslinkers in intact cells 
presents a possibility to capture transient protein interactions prior to affinity 
isolation153. By using chemical crosslinking, ER chaperones were shown to form 
multiprotein networks rather than existing as single, free proteins46.  Furthermore, the 
interaction between ERGIC-53 and the lysosomal glycoprotein cathepsin Z was also 
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identified by chemical crosslinking86. Although a powerful technique, chemical 
crosslinking can capture protein interaction partners only if they display crosslinkable 
chemical groups in the correct distance and orientation. Thus, not all protein-protein 
interactions are amenable to chemical crosslinking procedures.  
Concerning the detection of protein interactions with transmembrane proteins, 
affinity purification procedures can be used but require optimization. The analysis of 
high-throughput protein-protein interaction datasets revealed that affinity isolation-
based techniques often fail to detect protein interactions with transmembrane 
proteins due to the difficulty of their solubilization by standard procedures123.  
 
Protein microarrays 
It is potentially feasible to screen protein interactions by protein microarrays but the 
technique is still in a developmental stage. The requirement for sophisticated 
equipment as well as the lack of protein chips covering mammalian proteomes 
impedes the application of the microarray technology for the identification of novel 
luminal protein interactions at this stage. The risk of missing weak and transient 
protein interactions due to their detection in vitro is a further disadvantage of the 
protein microarray technology. Yet, an interesting application of the microarray 
technology is the analysis of protein-carbohydrate interactions since many important 
luminal protein interactions are carbohydrate-mediated and different carbohydrate 
structures can be synthesized on a chip66, 154. 
 
Yeast two-hybrid system 
The yeast-two hybrid system is well established for the identification of cytosolic 
protein interactions and has been also applied to luminal protein interactions in 
individual cases155 but is far from ideal to identify protein interactions in the lumen of 
the secretory pathway. Many interactions are missed due to misfolding and lack of 
correct disulfide bridges or post-translational modifications in luminal proteins if 
expressed in the yeast nucleus. Furthermore, the reducing nature and the low 
calcium levels of the yeast nucleus constitute a rather suboptimal environment for 
luminal protein interactions to take place. The restriction of the yeast-two hybrid 
system to soluble proteins is another disadvantage, but can be overcome by 
methods such as the split-ubiquitin system. Nevertheless, split-ubiquitin relies on a 
cleavage step by cytosolic proteases thereby limiting the analysis to cytosolic 
interactions of integral membrane proteins. 
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Protein fragment complementation assay 
The concept of protein fragment complementation can be applied to protein 
interactions in virtually every subcellular compartment. Limitations derive from the 
requisite that the reconstituted reporter protein must be functional and detectable in 
the particular subcellular compartment. The detection of luminal protein interactions 
would require a PCA reporter inside the lumen of the secretory pathway. A luminal 
PCA would monitor luminal protein interactions in their physiological environment, 
hence under oxidizing conditions and under high calcium levels. Since expressed in 
their native environment, most luminal bait and prey proteins would be correctly 
folded and contain the correct post-translational modifications due to access to the 
ER folding and modification machinery. Importantly, the technique of protein 
fragment complementation is applicable to protein interactions between soluble as 
well as membrane proteins but suffers, like the yeast-two hybrid system, from false 
negative and false positive hits140, 156. Of note, PCA-based cDNA library screening 
has been reported only for the identification of cytosolic protein interactions140. 
 
Summary 
Table 2 summarizes the advantages and disadvantages of the affinity purification-, 
protein microarray-, yeast two hybrid- and protein fragment complementation-based 
techniques. Not included are factors such as costs or amount and time of work. In 
terms of costs, mass spectrometry- and protein microarray-based approaches belong 
to the more expensive techniques due to the requirement of sophisticated 
instruments. Concerning amount and time of work, protein microarray- and protein 
fragment complementation-based screening strategies belong to the more labor-
intensive methods since they are still in their developmental stage.  
The evaluation of the different methods reveals that the protein microarray 
technology and the yeast two-hybrid system are not appropriate to identify luminal 
protein interactions at this stage. In contrast, the mass spectrometry-based 
characterization of purified protein complexes represents a powerful and broadly 
applicable strategy to analyze luminal protein interactions and can be combined with 
in vivo crosslinking procedures. A second promising strategy is based on the concept 
of protein fragment complementation. PCA-based techniques have not been applied 
to protein interactions in the secretory pathway but have the unique potential to 
capture luminal protein interactions in vivo, analogous to the yeast-two hybrid system 
for cytosolic protein interactions.   
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2. Aim of the thesis 
 
 
2.1 PCA-based analysis of luminal protein interactions  
 
The analysis of luminal protein interactions by protein fragment complementation 
holds the promise to uncover novel interactions missed by other methods. So far, β-
lactamase, dihydrofolate reductase, Renilla and firefly luciferase as well as 
fluorescent proteins were successfully applied as PCA reporters for the detection of 
cytosolic protein interactions. Can any of these PCA strategies be adopted to probe 
for protein interactions in the lumen of the secretory pathway? Since the yellow 
fluorescent protein (YFP) can be readily detected in the luminal environment of the 
ER, a YFP-based PCA approach was examined in this thesis regarding its potential 
to detect luminal protein interactions. ERGIC-53 and its interacting proteins MCFD2, 
cathepsin Z and cathepsin C were used as a proof of concept to test the feasibility 
and specificity of the method. Furthermore, a YFP PCA-based cDNA library 
screening strategy was established to identify interaction partners of ERGIC-53 in a 
genomewide setting. 
 
2.2 Characterization of the ERGIC-53/MCFD2 complex 
 
The identification of MCFD2 as a luminal interaction partner of ERGIC-53 led to the 
notion of cargo receptor complexes in the field of receptor-mediated ER export. Why 
do we need a cargo receptor complex? What is the function of MCFD2? Genetic and 
biochemical data show that MCFD2 is required for the secretion of blood coagulation 
factors V and VIII. It remains unknown, however, if MCFD2 functions as a specific 
factor for these proteins or has a more general role in the binding of cargo 
glycoproteins to ERGIC-53. Work in this thesis addressed the question of cargo 
selectivity of the ERGIC-53/MCFD2 receptor complex by combining cellular depletion 
of MCFD2 with YFP PCA-based quantification of the cargo binding properties of 
ERGIC-53. Moreover, the ERGIC-53/MCFD2 protein complex was dissected in 
regard of its localization and subunit interdependence. For this purpose, 
immunofluorescence-based protein localization studies were combined with short 
interference RNA (siRNA)-mediated protein knockdowns.  
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3. Results 
 
 
3.1 Capturing protein interactions in the secretory 
pathway of living cells 
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Fig. 6.  Reconstituted yellow fluorescent protein (YFP) fluorescence after YFP1-
p53 and YFP2-p53 oligomerization localizes to the early secretory pathway. 
HeLa cells coexpressing YFP1-p53 and YFP2-p53 were analyzed 24 h after 
transfection. Colocalization of the reconstituted YFP fluorescence with the 
endoplasmic reticulum marker BAP31, the ERGIC/cis-Golgi marker KDEL receptor, 
and the cis/medial-Golgi marker giantin demonstrates its localization to the early 
secretory pathway. 
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3.2 Development of a genomewide screening procedure 
to identify cargo proteins of ERGIC-53  
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Abstract 
 
ERGIC-53 is a transmembrane lectin which cycles in the early secretory pathway and 
acts as a cargo receptor for a subset of glycoproteins including cathepsin Z, 
cathepsin C and blood coagulation factors V and VIII. To address the question of 
whether ERGIC-53 captures additional cargo proteins, we developed a genomewide 
screening procedure based on the complementation of the yellow fluorescent protein 
(YFP). To this end, a cDNA-YFP1 fusion library was constructed, expressed in 
mammalian COS-1 cells and screened using YFP2-tagged ERGIC-53 as bait protein. 
COS-1 cells that contained complemented YFP were isolated by fluorescence 
activated cell sorting (FACS) and library plasmid were recovered and analyzed. Here 
we describe the evaluation of the different steps of the screening procedure and 
provide results of a first small-scale pilot screen which identified alpha-1-antitrypsin 
as a potential cargo protein of ERGIC-53. This finding suggests that ERGIC-53 might 
bind more glycoproteins than initially assumed. Furthermore, our results clearly 
demonstrate the feasibility to screen a cDNA library for luminal interaction partners of 
ERGIC-53 by means of fluorescence complementation. Thus, this study provides a 
firm basis for genomewide screening of protein-protein interactions inside the 
secretory pathway of mammalian cells. 
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Introduction 
 
The lumen of the endoplasmic reticulum (ER) provides a unique environment for 
proteins to be folded and modified1. One third of all newly synthesized proteins is co-
translationally inserted into the ER and processed in its oxidizing milieu by multiple 
ER resident enzymes. An elaborate ER quality control system monitors the 
conformational state of the folding substrates and retains them in the ER during the 
folding process2. While terminally misfolded proteins are re-translocated to the 
cytosol for degradation3, correctly folded proteins can be transported to the ER Golgi 
intermediate compartment (ERGIC) in coat protein II (COPII)-coated vesicles4. The 
Sec24 subunit of the COPII coat selectively recruits transmembrane proteins into 
anterograde vesicles by directly interacting with ER exit motifs in their cytosolic tails5. 
In turn, transmembrane proteins can capture soluble cargo proteins and incorporate 
them into COPII-coated vesicles6-9 according to the model of receptor-mediated ER 
export of soluble proteins. Although attractive, this model suffers from the low 
number of transmembrane receptors and cognate soluble cargo proteins which have 
been identified so far. The best characterized mammalian cargo receptor is the ER 
Golgi intermediate compartment protein-53 (ERGIC-53)10, 11. This type I membrane 
protein captures with its luminal domain soluble cargo proteins such as cathepsin Z, 
cathepsin C and blood coagulation factors V and VIII9, 12-14, while a di-hydrophobic 
ER exit motif in its cytosolic tail ensures packaging into COPII-coated vesicles15. Is 
ERGIC-53 a cargo receptor for only a small subset of glycoproteins? Are cathepsin Z, 
cathepsin C and blood coagulation factors V and VIII the only cargo proteins of 
ERGIC-53? Recent findings that ERGIC-53 also binds mutant immunoglobulin 
chains16 and nicastrin17 indicate the possibility of further, yet unidentified cargo 
proteins.  
For this reason, we set out to screen for ERGIC-53 cargo proteins in a 
genomewide setting. As a method of choice, a cDNA library screening strategy 
based on yellow fluorescence complementation was developed. The concept of 
yellow fluorescence complementation relies on fusing two non-fluorescent fragments 
of the yellow fluorescent protein (YFP) to two separate proteins which are then 
expressed in mammalian cells18. If the proteins interact, the two fragments of YFP 
are brought into close proximity which induces the correct folding and reconstitution 
of fluorescent YFP in vivo. In a previous study, we have provided the proof of 
concept for YFP complementation-based visualization of protein-protein interactions 
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inside the lumen of the secretory pathway. Using luminal YFP complementation, the 
oligomerization of ERGIC-53 as well as its interactions with cathepsin Z, cathepsin C 
and multiple coagulation factor deficiency protein 2 (MCFD2) was readily 
visualized19. With the identification of Ft1 as novel interaction partner of protein 
kinase B, fluorescence complementation-based cDNA library screening has been 
established for cytosolic protein interactions20, 21. The present study describes now 
the development of a screening procedure that is applicable inside the lumen of the 
secretory pathway. In order to screen for luminal protein-protein interactions, a 
human adult liver cDNA-YFP1 fusion library was constructed and assessed. The 
different steps in the screening procedure such as co-expression of bait and prey 
proteins, fluorescent-activated cell sorting (FACS), prey plasmid recovery and hit 
validation were evaluated. Furthermore, a small-scale pilot screen for ERGIC-53 
cargo proteins was undertaken which resulted in the identification of alpha-1-
antitrypsin as potential interaction partner of ERGIC-53. The development of this 
yellow fluorescence complementation-based cDNA library screening approach 
should be generally applicable for genomewide screening of protein-protein 
interactions in the lumen of the secretory pathway. 
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Results 
 
In order to screen for novel ERGIC-53 cargo proteins, a yellow fluorescence 
complementation-based cDNA library screening procedure was established as 
illustrated in Figure 1. ERGIC-53 was tagged with YFP fragment 2 (YFP2-ERGIC-53) 
and used as a bait while prey proteins were expressed from a cDNA-YFP1 fusion 
library (Figure 1A). Of note, YFP fragment 2 of the ERGIC-53 bait protein is localized 
to the lumen of the secretory pathway which restricts the screen to luminal protein-
protein interactions (Figure 1B). If mammalian cells co-express YFP2-ERGIC-53 with 
an interacting YFP1-tagged prey protein, the two non-fluorescent YFP fragments are 
brought into close proximity and can reconstitute fluorescent YFP. Yellow fluorescent 
cells harboring reconstituted YFP can be readily collected by FACS and used for the 
isolation and validation of prey plasmids (Figure 1C)21. 
 
Construction of the cDNA-YFP1 library  
YFP complementation-based screening of protein interactions inside the secretory 
pathway requires the translocation of both bait and prey proteins into the ER. Thus, 
in a cDNA library screening-based approach, it has to be ensured that library-
encoded prey proteins can reach the lumen of the ER. For this purpose, cDNA 
inserts were tagged at their C-terminus with YFP fragment 1 to preserve endogenous 
N-terminal signal sequences in membrane and secretory proteins. As a 
consequence, cDNA inserts have to contain their 5’ ends (to ensure the expression 
of the signal sequence) but lack their 3’ ends (to prevent the stop codon from 
terminating translation prior to YFP1). These requirements are difficult to meet and 
we first tried to construct a cDNA fusion library from scratch. For this purpose, liver 
mRNA was reverse transcribed using random primers, second strands were 
synthesized, and generated cDNAs were ligated, after linker addition and size 
fractionation, into a YFP1 containing mammalian expression vector. With around 105 
independent clones that harbored mainly small inserts deriving from mitochondrial 
DNA (data not shown), the generated library was not applicable to YFP 
complementation-based protein interaction screening. Therefore, we decided to 
switch to a cDNA library subcloning approach as depicted in Figure 2. cDNA inserts 
were subcloned from a human adult liver X-NubG library (Figure 2A) which has been 
initially constructed to screen protein-protein interactions using the split-ubiquitin 
system22. This library was chosen for the following reasons: (i) secretory proteins are 
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highly represented since adult liver, a secretory tissue, was used as source for cDNA 
library construction, (ii) N-terminal signal sequences of membrane and secretory 
proteins are preserved since random primers were utilized for reverse transcription 
which enriches the 5’ ends of cDNA inserts, (iii) the cDNA library has a high 
complexity containing plasmids from 1.3x106 independent clones, (iiii) cDNA inserts 
can be reliably subcloned via two SfiI restriction sites. Since cDNA inserts are flanked 
with two GGCCNNNNNGGCC SfiI recognition sites that differ in their 5 middle base 
pairs, subcloning can be performed without loss of orientation. In addition, the 14 
base pair long recognition site of SfiI is rare and cDNA inserts are unlikely to be 
fragmented during subcloning. 
To subclone the library, inserts were excised from the X-NubG library, 
separated by agarose gel-electrophoresis, purified according to their size and 
inserted into mammalian pcDNA3 expression vectors harboring YFP fragment 1 in all 
three reading frames (Figure 2C and D). The subcloning strategy resulted in a cDNA-
YFP1 library that contained plasmids from approximately 106 independent clones 
with cDNA inserts ranging from 1 to 2.5kb in size (Figure 3A). 
 
Assessment of the quality of the cDNA-YFP1 library  
To evaluate the cDNA-YFP1 library, 16 randomly picked plasmids were analyzed for 
insert size and insert properties. For this purpose, inserts were excised by SfiI and 
sequenced. The digestion with SfiI demonstrated that all 16 clones contained inserts 
of a 1 to 2.5 kb size range (Figure 3B). Furthermore, sequence analysis revealed that 
14 of 16 clones contained cDNA inserts coding for proteins of already known function 
while one clone contained an uncharacterized open reading frame and one clone 
could not be sequenced (Figure 3C). In order to express a functional YFP1 fusion 
protein, a cDNA insert should contain its start codon to initiate translation but should 
lack a stop codon prior to the YFP fragment 1. Hence, the 14 clones that contained 
cDNA inserts of known proteins were examined for containing their start codon but 
lacking a stop codon. While all 14 cDNA inserts contained their start codon, 6 lacked 
their stop codon which indicates that around 40% of the cDNA inserts (6 out of 14) 
are present in a functional manner. In addition, cDNA inserts were analyzed for 
having an N-terminal signal sequence. 7 out of the 14 cDNA inserts indeed contained 
an N-terminal signal sequence suggesting that membrane and secretory proteins are 
highly represented in the generated cDNA-YFP1 library. To complete the evaluation 
of the cDNA-YFP1 library, we tested if its co-expression with the YFP2-ERGIC-53 
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bait protein was able to reconstitute YFP molecules. As shown in Figure 3D, co-
expression of YFP2-ERGIC-53 with the cDNA-YFP1 library in HeLa cells led to the 
detection of around 0.1% yellow fluorescent cells which were absent if YFP2-ERGIC-
53 or the cDNA-YFP1-library were expressed alone. This indicates that the cDNA-
YFP1 library expresses functional YFP1 fusion proteins which can interact with 
YFP2-ERGIC-53 and can reconstitute fluorescent YFP. 
 
Plasmid recovery from FACS-sorted cells 
A crucial point in the YFP complementation-based cDNA library screen represents 
the expression and recovery of library plasmids. Standard transfection reagents, 
including FuGENE6, transfect several plasmids per cell and thereby allow high 
protein expression levels. Since libraries contain many different plasmids, one can 
not rely on the uptake of multiple copies of the same plasmid per cell. Therefore, we 
performed the library screen in COS-1 cells that express the large T antigen and can 
replicate transfected plasmids containing the SV40 eukaryotic origin of replication23. 
Upon replication by COS-1 cells, each cDNA-YFP1 library plasmid is present  in 
multiple copies per transfected cell which guarantees sufficient prey protein 
expression and enhances the chances for the subsequent recovery of the library 
plasmid. As depicted in Figure 4A, YFP2-ERGIC-53 was co-transfected with the 
cDNA-YFP1 library or two control plasmids. As negative and positive control 
plasmids, HA- and YFP1-tagged MCFD2 were used, respectively. To limit the 
transfection of YFP1-MCFD2 in the positive control sample to maximally one plasmid 
copy per cell, YFP1-MCFD2 was diluted 1:1000 in an excess of MCFD2-HA negative 
control plasmid. Furthermore, bait and prey plasmids were transfected at a ratio of 
10:1 to ensure that all transfected cells take up the bait plasmid but only a minimal 
number of prey plasmids. FACS-based analysis revealed no yellow fluorescent cells 
for the negative control, while 0.23% and 0.10% yellow fluorescent cells were 
detectable for the positive control and the library sample, respectively (Figure 4A and 
B). This result clearly confirms that the cDNA-YFP1 library indeed expresses 
interaction partners of YFP2-ERGIC-53 and can reconstitute yellow fluorescence. 
The analysis of yellow fluorescence intensities indicates that the library sample 
shows two to three times lower signals if compared to the positive control.  
To evaluate plasmid recovery from FACS-sorted cells, 500 yellow fluorescent 
cells were collected from the positive control sample. Total DNA was isolated and 
transformed into bacteria which were then grown on ampicillin-containing plates to 
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recover only clones harboring prey plasmids. This procedure resulted in 600 
transformants which corresponds to approximately one recovered plasmid per sorted 
cell. Since YFP1-MCFD2 was diluted 1:1000 in the MCFD2-HA negative control, the 
amount of MCFD2-HA in the recovered prey plasmids is indicative for the number of 
plasmids which are co-transfected together with YFP1-MCFD2 but do not contribute 
to fluorescence complementation. In order to determine the ratio of YFP1-MCFD2 
and MCFD2-HA, individual transformants were picked and analyzed by PCR screen. 
From 64 checked transformants, 9 contained YFP1-MCFD2 while 53 contained 
MCFD2-HA (Figure 4C). The recovery of YFP1-MCFD2 in 9 cases demonstrates the 
feasibility to recover and enrich prey plasmids which are ‘positive’ for fluorescence 
complementation. Nevertheless, the detection of MCFD2-HA in 54 cases indicates 
that the majority of recovered prey plasmids represent co-transfected plasmids which 
have not contributed to fluorescence complementation. The possibility that missorted 
cells interfere with this analysis is unlikely, since FACS-sorting resulted in a 95% pure 
population of yellow fluorescent cells (data not shown). The finding that only every 
seventh recovered prey plasmids is ‘positive’ and has contributed to fluorescence 
complementation implies that a rather high number of prey plasmids need to be 
validated in the library screen.  
 
Screening for ERGIC-53 interaction partners 
To test if ERGIC-53 interaction partners can be identified by screening the cDNA-
YFP1 library, a small scale pilot screen was performed. To this end, yellow 
fluorescent cells were collected by FACS from the library sample (Figure 4A and 4B). 
From a total of 2x106 cells, 500 fluorescent cells were sorted and used to isolate total 
DNA. Transformation of the isolated DNA into bacteria resulted in about 500 
transformants which corresponds again to one recovered prey plasmid per sorted 
cell. Subsequently, cDNA-YFP1 library plasmids were isolated from 24 individual 
transformants, co-expressed with YFP2-ERGIC-53 in COS-1 cells and validated by 
fluorometric analysis (Figure 5A).  From the 24 screened library plasmids, plasmid 
number 17 reconstituted significant yellow fluorescence upon co-transfection with 
YFP2-ERGIC-53 (Figure 5B). The analysis of library plasmid number 17 by SfiI 
digestion revealed an insert size of approximately 1.3 kb (Figure 5C) and sequencing 
identified the insert as alpha-1-antitrypsin. It is of note, that the start codon, the signal 
sequence, and all amino acids of alpha-1-antitrypsin except the last two are present 
in library plasmid 17 (Figure 5D). Since fusion to YFP fragment 1 is in frame, library 
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plasmid 17 expresses YFP1 tagged alpha-1-antitrypsin in a functional manner. The 
identification of alpha-1-antitrypsin in the small-scale screen for ERGIC-53 cargo 
proteins clearly demonstrates that yellow fluorescence complementation-based 
cDNA library screening is a powerful approach to identify potential interaction 
partners of ERGIC-53.  
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Discussion 
 
The identification of ERGIC-53 cargo proteins is hampered by the weak and transient 
nature of the underlying protein-protein interactions. While standard affinity 
purification procedures fail to isolate cargo proteins of ERGIC-53, chemical 
crosslinking procedures have been successfully applied to detect the interactions 
between ERGIC-53 and its cargo proteins cathepsin Z9 and blood coagulation factor 
VIII14. However, not all protein-protein interactions are amenable to crosslinking as 
exemplified by the inability to chemically crosslink cathepsin C to ERGIC-5313. With 
the application of the YFP protein fragment complementation assay (PCA) to 
interactions in the lumen of the secretory pathway, a technique has been developed 
for capturing cargo proteins of ERGIC-53 in a sensitive and specific manner19. While 
YFP PCA-based visualization of the interactions between ERGIC-53 and cathepsin 
Z, cathepsin C or MCFD2 was based on already known or suspected protein 
interactions, the present study extends the application of luminal YFP 
complementation to the identification of novel protein interactions. The feasibility of 
fluorescence complementation-based cDNA library screening is demonstrated by 
pulling out YFP1-tagged alpha-1-antitrypsin from a cDNA-YFP1 library as interaction 
partner of YFP2-ERGIC-53. Alpha-1-antitrypsin was identified in a small scale screen 
of 24 recovered library plasmids. An up-scaled version of this screen holds the 
promise to identify further interaction partners of ERGIC-53. Our small scale screen 
also reveals that the majority of recovered prey plasmids (23 out of 24) are not able 
to significantly reconstitute yellow fluorescence if individually expressed with YFP2-
ERGIC-53. This finding is in agreement with the recovery of the many MCFD2-HA 
plasmids (53 out of 64) from the positive control sample. Thus, several prey plasmids 
are taken up per cell during transfection while only very few really contribute to 
fluorescence complementation. In order to obtain a reasonable number of validated 
hits, either a high number of library plasmids need to be screened, or transfection 
conditions have to be optimized. By minimizing the amount of transfected DNA and 
transfection reagent and by using ten times less prey than bait plasmids, we have 
already minimized to a certain extent the number of library plasmids taken up per 
cell. Nevertheless, other transfection methods such as electroporation should be 
tested for their ability to transfect even fewer plasmid copies per cell. In the case of 
electroporation, the YFP2-ERGIC-53 bait protein should be stably transfected into 
COS-1 cells to ensure its expression.  
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Our pilot screen identified an interaction of alpha-1-antitrypsin and ERGIC-53. 
Several considerations support the specificity of this interaction. First, YFP PCA has 
been shown to capture protein interactions between ERGIC-53 and its cargo proteins 
in a specific manner19. Second, the detection of only 0.1% yellow fluorescent cells 
upon co-transfection of YFP2-ERGIC-53 and the cDNA-YFP1 library argues against 
an unspecific protein-protein interaction. Third, an almost full-length version of alpha-
1-antitrypsin was expressed since library plasmid number 17 contains the complete 
coding sequence of alpha-1-antitrypsin except the last two amino acids. This 
increases the likelihood that alpha-1-antitrypsin is present in its native conformation 
and does not unspecifically stick to ERGIC-53. Fourth, since ERGIC-53 is a 
mannose-binding lectin and alpha-1-antitrypsin is triply N-glycosylated, the detected 
interaction might be carbohydrate-mediated. The carbohydrate-dependence of the 
interaction between alpha-1-antitrypsin and ERGIC-53, can be probed by YFP PCA 
using the lectin deficient ERGIC-53 N156A mutant. 
The interaction between alpha-1-antitrypsin and ERGIC-53 needs to be 
verified by a YFP PCA independent approach. One possibility is to probe the 
interaction by chemical crosslinking in hepatoma cell lines such as HepG2 which 
express both alpha-1-antitrypsin and ERGIC-53 endogenously.  
In conclusion, this study has two major implications. First, YFP 
complementation can be successfully applied to screen cDNA libraries for novel 
protein-protein interactions in the lumen of the secretory pathway. Second, ERGIC-
53 might bind more glycoproteins than initially assumed. An up-scaled version of this 
screen will allow the search for ERGIC-53 cargo proteins in a genomewide setting 
and should be generally applicable to luminal protein-protein interactions in the 
secretory pathway. 
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Material and Methods 
 
Construction of pcDNA3[SfiI-linker-YFP1] vectors for library subcloning 
Linker-YFP1 fragments covering all three reading frames of YFP fragment 1 were 
PCR amplified from pcDNA3[MCFD2-YFP1]19 using 5’-CTA AAG CTT GGT GGC 
GGT GGC TCT GGA GG-3’ (reading frame 1), 5’-CTA AAG CTT AGG TGG CGG 
TGG CTC TGG AGG-3’ (reading frame 2) or 5’-CTA AAG CTT CAG GTG GCG GTG 
GCT CTG GAG G -3’ (reading frame 3) as forward and 5’-TAC GGC TCG AGT TAC 
TTG TAC AGC TCG TCC ATG C -3’ as reverse primers. PCR fragments were cloned 
into the pCMV-Script vector (Stratagene) via the HindIII and XhoI sites. It is of note 
that YFP1 contains the citrine mutation (Q69M)19, 25. Two SfiI restriction sites were 
introduced into the pCMV[linker-YFP1] vector by inserting annealed and 
phosphorylated 5’- AAT TCG GCC ATT ACG GCC AGG CCT TTA ATT AAG GCC 
GCC TCG GCC-3’ and 5’- AGC TGG CCG AGG CGG CCT TAA TTA AAG GCC 
TGG CCG TAA TGG CCG-3’ oligos via the EcoRI and HindIII sites. Finally, the SfiI-
linker-YFP1 fragments were subcloned from the pCMV vector into the pcDNA3 vector 
(Invitrogen) via EcoRI and XhoI. The pcDNA3[YFP1] vectors covering all three 
reading frames are illustrated in Figure 2 C and D and were verified by sequencing. 
 
Generation of cDNA-YFP1 library 
A human adult liver cDNA-NubG library (Dualsystems) was digested for 3h with SfiI 
(NEB) at 50°C and the product was separated by agarose gel-electrophoresis. DNA 
was visualized by ethidium bromide, and inserts were excised from the gel in four 
fractions according to size (fraction A: 4-2.5kb, fraction B: 2.5-1.5kb, fraction C: 1.5-
1kb, fraction D: 1-0.3kb). The four insert fractions were purified using the QIAquick 
gel extraction kit (QIAGEN) and ligated into SfiI digested, dephosphorylated and gel 
purified pcDNA3[YFP1] vectors. Ligation products were ethanol precipitated and 
transformed into competent MC1061 bacteria26 by electroporation. Transformed 
bacteria were plated onto LB-plates containing 100μg/ml ampicillin and grown over 
night at 30°C. For each of the four cDNA fractions, eight transformants were picked, 
amplified in liquid culture before plasmids were isolated using the GenElute Plasmid 
Miniprep kit (SIGMA). Isolated plasmids were then analyzed by SfiI digest and 
sequenced using 5’-CAA ATG GGC GGT AGG CGT GTA CG-3’ as forward and 5’-
CGT CCA GCT CGA CCA GGA TGG-3’ as reverse primer. Transformants deriving 
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from insert fraction A contained mainly a contaminating, 2.5 kb large, ampicillin 
resistant vector harboring no cDNA insert. Transformants deriving from insert 
fractions B and C contained various cDNA inserts differing in size and nature (Figure 
3C). Transformants deriving from insert fraction D contained mainly products from 
mitochondrial genome. Consequently, insert fractions B and C were chosen to 
generate the final cDNA-YFP1 library. Ligation, transformation and platting were 
scaled up until a total of around 1x106 transformants was obtained. All transformants 
were scraped into LB medium, pooled and library plasmids were isolated using the 
Plasmid Maxi kit (QIAGEN).  
 
Construction of the YFP2-ERGIC-53 bait plasmid 
The YFP2-ERGIC-53 bait was constructed in the pCMV-Script vector by two 
subsequent subcloning steps. First, the SS-YFP2 fragment was subcloned from 
pcDNA3[SS-YFP2-catZ]19 into the pCMV vector using EcoRI. ERGIC-53 lacking its 
endogenous signal sequence was then subcloned from pcDNA3[SS-YFP2-ERGIC-
53]19 using XhoI. The pCMV[SS-YFP2-ERGIC-53] construct was verified by 
sequencing. 
 
Cell Culture and Transfection 
HeLa cells (ATCC, CCL-2) were grown in DMEM, supplemented with 10% fetal 
bovine serum, 1x non-essential amino acids and antibiotics. COS-1 cells (ATCC, 
CRL-1650) were grown in DMEM, supplemented with 10% fetal bovine serum and 
antibiotics. For FACS analysis and fluorometric analysis cells were grown in 35mm 
dishes while cells for FACS sorting were grown 100mm dishes. Cells were 
transfected 24h after plating using FuGENE6 (Roche Applied Science). Cells in 
35mm dishes were transfected with 1.5μl FuGENE6 and 500ng DNA and cells in 
100mm dishes were transfected with 7.5μl FuGENE6 and 2.5μg DNA. Bait and prey 
plasmids were co-transfected at a ratio of 10:1. 
 
FACS Analysis and Sorting 
48h after transfection, cells were washed with PBS, trypsinized and resuspended in 
PBS containing 0.1% bovine serum albumin and 5mM EDTA. FACS analysis was 
performed on a CYAN ADP analyzer (Dako) using the Summit v4.3 software (Dako). 
Cell sorting was performed on a FACS Vantage SE (Becton Dickinson). An excitation 
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wavelength of 488nm was used and emission was recorded at 530nm (green 
fluorescence) and 680nm (red fluorescence). FuGENE6 transfected COS-1 cells 
showed significant autofluorescence. Plotting of green versus red fluorescence 
resulted in autofluorescent cells lying in the diagonal. Consequently, YFP expressing 
cells could be exclusively detected in the green fluorescent channel which allowed 
accurate analysis and sorting. 
 
Recovery of prey plasmids 
Genomic DNA was isolated from FACS-sorted cells using the DNeasy Tissue kit 
(QIAGEN) according to the manufacturer’s instructions. The isolated DNA was 
ethanol precipitated, resuspended in 10μl water and transformed into XL-10 gold 
ultracompetent bacteria (Stratagene).  Transformed bacteria were grown over night 
at 37°C on LB-plates containing 100μg/ml ampicillin. Ampicillin selects  transformants 
that harbor prey plasmids since only prey plasmids contain the ampicillin resistance 
marker. Transformants were either probed by PCR screen or amplified in liquid 
culture before plasmids were isolated using the GenElute Plasmid Miniprep kit 
(SIGMA). 
 
PCR Screen 
Individual transformants were picked, transferred into 20μl water, boiled and probed 
by PCR using the FastStart PCR Master (Roche Applied Science) and 5’-GAA CCC 
ACT GCT TAC TGG CTT ATC G-3’ as forward and 5’-TGG CAA CTA GAA GGC 
ACA GTC GAG G-3’ as reverse primer. The two primers anneal to the pcDNA3 
vector backbone and amplify 1149bp and 666bp fragments for pcDNA3[SS-YFP1-
MCFD2]19 and pcDNA3[SS-HA-MCFD2], respectively. PCR products were separated 
by agarose gel-electrophoresis and visualized by ethidium bromide staining.  
 
Fluorometric analysis 
Fluorometric analysis was performed as described previously19.  
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Figure Legend 
 
Figure 1: Yellow fluorescence complementation-based cDNA screening for 
ERGIC-53 interaction partners. 
Fluorescence complementation was applied to screen a cDNA library for ERGIC-53 
interaction partners. To this end, a cDNA-YFP1 library was generated to express 
YFP1-tagged prey proteins while YFP2-ERGIC-53 was used as bait. The cDNA-
YFP1 library and YFP2-ERGIC-53 were constructed in mammalian expression 
vectors harboring the bacterial markers for ampicillin and kanamycin resistance, 
respectively (A). To probe protein-protein interactions, YFP2-ERGIC-53 and prey-
YFP1 fusion proteins were co-expressed in mammalian COS-1 cells. Yellow 
fluorescence is only detectable if YFP2-ERGIC-53 is co-expressed with an interacting 
YFP1 fusion protein which brings YFP fragments 1 and 2 into close proximity and 
allows reconstitution of YFP (B). Yellow fluorescent cells were collected by 
fluorescence-activated cell sorting (FACS) and DNA was isolated and transformed 
into bacteria which were then grown on ampicillin-containing plates to selectively 
recover prey plasmids. In order to validate the interaction with ERGIC-53, prey 
plasmids were isolated and individually analyzed for YFP complementation upon co-
expression with YFP2-ERGIC-53 (C).  
 
Figure 2: Construction of the cDNA-YFP1 library 
The cDNA-YFP1 library applied in this study was generated by subcloning cDNA 
inserts from a cDNA-NubG library. Information regarding the source, construction 
method, library vector, complexity, average insert size as well as insert size range of 
the cDNA-NubG library is indicated (A). cDNA inserts were excised from the cDNA-
NubG library by SfiI digest, fractionated according to their size, purified and 
subcloned into the mammalian pcDNA3 expression vector containing YFP fragment 
1 as schematically depicted in (B). A detailed map of the pcDNA3[YFP1] vector is 
illustrated (C). cDNA inserts were ligated into the vector via the two indicated SfiI 
restriction sites just in front of the linker-YFP1 fragment. The ten amino acid 
GGGGSGGGGS linker precedes YFP1 to ensure flexibility of YFP fragment 1 for 
fluorescence complementation.  While the SV40 origin of replication allows plasmid 
amplification in mammalian cells harboring the large T-antigen, expression of YFP1 
fusion proteins is guaranteed by the CMV promoter in the pcDNA3 vector. To cover 
all possible reading frames in pcDNA3[YFP1], inserts of 0, 1 or 2 base pairs (orange) 
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were introduced between the SfiI sites (blue) and the linker region (green). The 
translation products of the three reading frames are illustrated (D).  
 
Figure 3: Assessment of the quality of the cDNA-YFP1 library 
The subcloning strategy depicted in Figure 2 resulted in the construction of a cDNA-
YFP1 library with a complexity of about 1x106 clones. To assess the quality of the 
cDNA-YFP1 library, inserts were excised by SfiI digestion using either the total library 
(A) or 16 randomly picked clones (B). SfiI digestion of the total library reveals a 
smear of cDNA inserts ranging from around 1 to 2.5 kb in size while the analysis of 
the 16 individual clones demonstrates that DNA inserts are present in all plasmids. 
To characterize the inserts of the 16 picked clones, plasmids were sequenced.  
Sequence analysis was used to identify the inserts and to test if the inserts contained 
their start and stop codon and a N-terminal signal sequence (C). Note that the cDNA-
YFP1 library is enriched in secretory and membrane proteins harboring N-terminal 
signal sequences and includes many functional cDNA inserts containing their start 
codon but lacking their stop codon. In order to evaluate if the cDNA-YFP1 library can 
express prey proteins that interact with YFP2-ERGIC-53 and thereby reconstitute 
yellow fluorescence, HeLa cells were transfected and subjected to FACS-based 
analysis (D). While no yellow fluorescent cells were detectable for cells transfected 
with either YFP2-ERGIC-53 or the cDNA-YFP1 library alone, 0.1% yellow fluorescent 
cells appeared in the case of co-transfected cells. 
 
Figure 4: Plasmid recovery from FACS-sorted cells 
YFP2-ERGIC-53 was co-expressed in COS-1 cells with either MCFD2-HA as 
negative control, 1:1000 diluted YFP1-MCFD2 as positive control or the cDNA-YFP1 
library (A). 48h after transfection, yellow fluorescent cells were analyzed by FACS 
(B). Note that yellow fluorescent cells were absent in the negative control sample 
while 0.23% and 0.10% yellow fluorescent cells were detectable in the positive 
control and library sample, respectively. In order to evaluate plasmid recovery, yellow 
fluorescent cells were FACS-sorted from the positive control sample, total DNA was 
isolated and transformed into bacteria which were then grown on ampicillin-
containing plates to select transformants that contained prey plasmids. From the 600 
obtained transformants, 64 were probed by PCR screen for containing either YFP1-
MCFD2 or MCFD2-HA (C). The recovery of pcDNA3[YFP1-MCFD2] in just 9 cases 
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indicates that approximately only every seventh prey plasmid is ‘positive’ in the sense 
of having contributed to yellow fluorescence complementation.  
 
Figure 5: Screening for ERGIC-53 interaction partners 
To screen for ERGIC-53 interaction partners, COS-1 cells were co-transfected with 
YFP2-ERGIC-53 and the cDNA-YFP1 library, yellow fluorescent cells were collected 
by FACS and library plasmids were recovered as described in Material and Methods.  
24 isolated library plasmids were individually expressed with YFP2-ERGIC-53 in 
COS-1 cells which were then subjected to fluorometric analysis (A). MCFD2-HA and 
YFP1-MCFD2 were used as negative and positive controls, respectively. Note that 
library plasmid 17 induced significant yellow fluorescence upon co-transfection with 
YFP2-ERGIC-53. This finding was confirmed by re-transfecting COS-1 cells and re-
measuring yellow fluorescence by fluorometric analysis (B). SfiI digestion of library 
plasmid 17 excised a 1.3 kb insert (C) which was identified as alpha-1-antitrypsin by 
sequencing (D). The red bar marks the region of the alpha-1-antitrypsin mRNA and 
protein which is represented in library plasmid 17.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Yellow fluorescence complementation-based cDNA screening for 
ERGIC-53 interaction partners. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results  67 
 
 
Figure 2: Construction of the cDNA-YFP1 library. 
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Figure 3: Assessment of the quality of the cDNA-YFP1 library. 
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Figure 4: Plasmid recovery from FACS-sorted cells 
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Figure 5: Screening for ERGIC-53 interaction partners 
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3.3 Cargo selectivity of the ERGIC-53/MCFD2 transport 
receptor complex 
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4. Conclusions and Perspectives 
 
4.1 YFP PCA-based analysis of protein interaction 
 
4.1.1 Proof of concept of luminal YFP PCA 
In this thesis, I addressed the question of whether YFP protein fragment 
complementation is a suitable tool to analyze protein-protein interactions in the lumen 
of the secretory pathway by studying ERGIC-53 and its luminal interaction partners1. 
The results clearly demonstrate the feasibility and simplicity of the luminal YFP PCA 
in visualizing the homo-oligomerization of ERGIC-53 as well as its interaction with 
cathepsin Z, cathepsin C and MCFD2.  Thus, the luminal YFP PCA is applicable to 
protein interactions involving both integral membrane and soluble proteins. 
Additionally, the specificity of the luminal YFP PCA was demonstrated by showing 
that a mutation of the ERGIC-53 lectin domain selectively decreased the 
carbohydrate-mediated interactions with cathepsin Z and cathepsin C. Furthermore, 
the luminal YFP PCA was successfully applied to establish the cargo selectivity of 
the ERGIC-53/MCFD2 receptor complex in vivo. By using a YFP PCA-based 
quantification in MCFD2-depleted cells, ERGIC-53 was shown to bind glycoproteins 
in a MCFD2-independent manner. Finally, the potential of the luminal YFP PCA to 
identify novel protein-protein interactions was demonstrated in a small scale cDNA 
library screen. In a pilot screen, alpha-1-antitrypsin was identified from a cDNA-YFP1 
fusion library as potential interaction partner of ERGIC-53. With the development of 
this YFP complementation-based cDNA library screening procedure, a firm basis is 
provided to search for luminal protein interaction partners in a genomewide setting. 
Collectively, these results clearly demonstrate that YFP PCA is an attractive tool to 
study and screen protein-protein interactions inside the secretory pathway.  
 
4.1.2 Evaluation of fluorescence complementation 
Fluorescent protein fragment complementation has been applied to many different 
protein interactions since its discovery2, 3. A key attraction of a fluorescent protein as 
PCA reporter is the possibility to visualize protein interactions in living cells and to 
determine the intracellular localization of functional protein complexes. This is of 
importance since a protein might be distributed throughout the cell while performing 
its biological function only in a specific subcellular compartment due to restrictive 
localization of interacting proteins. While immunofluorescence-based approaches 
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stain the total pool of a protein, YFP PCA can be used to selectively visualize the 
fraction of functional protein found in a complex. This is relevant for many luminal 
protein interactions occurring in the process of protein folding and modification. 
Grp78, for example, binds just the non-native fraction of a protein which constitutes 
only a small subfraction of the total protein and is difficult to analyze by conventional 
methods.  
By combining fragments of green, yellow, cyan and blue fluorescent proteins, 
multicolor fluorescence complementation assays were developed that can visualize 
multiple protein interactions in a single cell4. Importantly, multicolor fluorescence 
complementation can be used to examine competitive protein interactions in 
complexes where several proteins compete for the same interaction partner5.  
Like every method, YFP PCA harbors not only advantages. The properties of 
fluorescence complementation are determined by the folding kinetics and the stability 
of GFP and its colour variants. GFP folds into an 11-stranded β-barrel containing a 
co-axial α-helix6. Once assembled, this structure is very stable making fluorescence 
complementation an essentially irreversible process7. Irreversibility facilitates the 
capture of transient protein interactions but complicates the analysis of dissociation 
processes in protein complexes. For example, one can think of two transcription 
factors which interact in the cytosol and translocate together into the nucleus where 
they dissociate again. In a fluorescence complementation-based analysis, the 
stabilization of the interaction between the two transcription factors could result in a 
false positive fluorescence signal in the nucleus. Therefore, the consequences of 
trapping interaction partners by association of the fluorescent protein fragments have 
to be analyzed in detail. In the case of ERGIC-53, the dissociation of cathepsin Z was 
prevented after YFP fragment complementation1 and the process of cargo protein 
release could not be studied by YFP PCA. For releasing cathepsin Z, ERGIC-53 was 
proposed to undergo a pH-induced conformational change8 which might not be 
powerful enough to dissociate the YFP fragments after complementation. To address 
the dynamic features of protein interactions, a fluorescence resonance energy 
transfer (FRET)-based approach should be used9, 10. FRET relies on the transfer of 
energy, in form of excitation energy, between fluorescent donor and acceptor 
molecules. To study protein-protein interaction by FRET, a pair of interacting proteins 
is tagged with two spectrally distinct full-length fluorescent proteins whose 
fluorescence intensities and lifetimes are measured. Since FRET strictly depends on 
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the distance between the donor and acceptor fluorescent protein and since full-length 
fluorescent proteins interact only minimally with each other11, a FRET-based 
approach can readily determine the dynamic behavior of protein complexes in real-
time12.     
Protein fragment complementation probes binary interactions between 
recombinant fusion proteins. The need to express fusion proteins has two major 
drawbacks, namely false negative hits caused by the steric hindrance of the fusion 
proteins and false positive hits due to overexpression of the interaction partners13. 
Depending on the localization of the tag, complementation may be hindered due to 
distance or orientation constraints. Peptide linkers between the proteins and the 
reporter fragments minimize but do not completely avoid the problem of steric 
hindrance. Thus, a ‘non-interaction’ prediction for a protein pair based on protein 
fragment complementation has to be further analyzed in terms of steric constraints. A 
possible solution to the problem of steric hindrance might be a transposon-based 
random tagging strategy. Random tagging of the glutamate receptor subunit GluR1 
with a transposon that contained GFP was reported to be an efficient way to select 
functional GFP insertion sites14. By taking advantage of in vitro transposition, a YFP 
fragment 1 or 2 containing transposon could be used to generate a whole population 
of randomly tagged proteins. After co-expression of this tagged protein population 
with its potential interaction partner, a FACS-based analysis may reveal if the 
population contains complementation-competent fusion proteins. Since in vitro 
transposition generates a huge diversity of different fusion proteins14, sterical 
constraints should be overcome. 
The problem of false positive hits due to the overexpression of interaction 
partners is a common problem of many methods in interaction proteomics. For 
fluorescence complementation, the problem of overexpression artefacts is further 
enhanced by the intrinsic tendency of the fluorescent protein fragments to self-
associate3. In yeast, recombinant DNA can be introduced into the genome by 
homologous recombination15. This allows the expression of recombinant proteins 
from their endogenous promoter at physiological levels. Mammalian cells are not 
easily amenable to homologous recombination and require viral- or plasmid-based 
expression of the recombinant proteins which often results in expression levels much 
higher than those of the corresponding endogenous proteins. Nevertheless, 
overexpression artefacts can be minimized by using expression vectors with weak 
promoters, by optimizing the transfection conditions in terms of transfection reagent 
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and transfected DNA amount and by controlling the expression time. An expression 
level comparable to the endogenous protein is desirable and can be assessed by 
Western blotting. In the case of ERGIC-53, the luminal YFP PCA visualized 
interaction partners of ERGIC-53 in a specific manner since the YFP1-p53 and 
YFP2-p53 bait proteins were expressed at a moderate level similar to that of 
endogenous ERGIC-53.   
 
4.1.3 Future prospects 
What are the perspectives for the luminal YFP PCA? It will be exciting to search for 
ERGIC-53 interacting proteins in a genomewide setting by scaling up the 
fluorescence complementation-based cDNA library screen using YFP2-ERGIC-53 as 
bait protein. Also other luminal bait proteins may be used since fluorescence 
complementation-based cDNA library screening can be generally applied to luminal 
proteins. The animal lectin vesicular integral-membrane protein 36 (VIP-36) is an 
attractive candidate. Like ERGIC-53, VIP-36 is proposed to act as a cargo receptor 
but not a single interaction partner has been identified so far16-18.  
In another promising approach, one could try to map the multiprotein network 
of ER resident proteins19, 20. For this purpose, important players in the ER folding and 
modification process would be tagged with YFP fragments 1 or 2 and probed against 
each others. To avoid overexpression artefacts, this approach should be performed 
in yeast cells taking advantage of homologous recombination. A detailed mapping of 
the ER multiprotein network might result in a more system-based view of protein 
folding and modification in the ER.  
Since fluorescence complementation is an irreversible process, dynamic 
properties of protein interactions can not be reliably studied. To analyze the 
numerous transient protein interactions in the lumen of the secretory pathway in real 
time, a reversible PCA would be of exceptional importance. By destabilizing the 
protein interaction interface between the two PCA reporter fragments by systematic 
amino acid mutations, a reversible PCA might be developed. Since fluorescent 
proteins fold into a very stable β-barrel structure, other PCA reporter proteins such as 
Renilla luciferase should be preferentially used for the development of a reversible 
PCA. Once established, a reversible PCA would also allow the screening of 
compound libraries for their potential to modulate protein interactions. With its 
increasing implications in diabetes, neurodegeneration and cancer21, UPR signaling 
Conclusions and Perspectives 86 
 
displays an attractive target for a compound library screen. Bortezomib is an example 
of a chemical compound that links ER stress signaling with cancer therapy22. 
Bortezomib is a proteasome inhibitor, which enhances ER stress but at the same 
time seems to inhibit PERK-mediated UPR signaling and render cancer cells more 
sensitive to chemotherapy23, 24. The mammalian UPR is induced by ER stress-
mediated dimerization of the transmembrane stress sensors IRE1 and PERK and by 
ER stress-regulated ER to Golgi trafficking of ATF625. A reversible PCA that monitors 
the dimerization of IRE1 or PERK might provide a basis to screen for additional 
chemical compounds which modulate UPR signaling thereby identifying novel 
potential drug candidates.  
 
4.2 Receptor-mediated ER export 
4.2.1 Characterization of the ERGIC-53/MCFD2 protein complex 
ERGIC-53 and MCFD2 are both required for the efficient secretion of blood 
coagulation factors V and VIII26, 27. Since ERGIC-53 and MCFD2 interact not only 
with each other but also with blood coagulation factor VIII, the existence of a cargo 
receptor complex composed of a transmembrane and a soluble protein was 
proposed28. This raises the intriguing possibility that a luminal protein interacts with 
cargo proteins and recruits them to a transmembrane receptor for ER export. To gain 
further insight into cargo receptor complexes, the ERGIC-53/MCFD2 protein complex 
was characterized in this thesis with regard to subunit interdependence, localization, 
and cargo binding properties. The data strongly suggest that ERGIC-53 and MCFD2 
form a stable protein complex since the endogenous proteins cycle in the early 
secretory pathway and interact in both ER and ERGIC. Noteworthy, MCFD2 depends 
on ERGIC-53 for intracellular retention. How does MCFD2 bind to ERGIC-53? 
Pulldown experiments revealed that MCFD2 requires the presence of calcium and 
two intact EF-hand motifs for its interaction with ERGIC-53. EF-hand motifs are 
calcium binding helix-loop-helix protein structures which can be found in more than 
200 different calcium binding proteins29. Most of these proteins are cytosolic albeit 
some EF-hand containing luminal proteins are known. The luminal proteins Cab45, 
reticulocalbin, Erc-55 and calumenin contain multiple EF-hand domains and 
constitute a protein family termed CREC with yet unidentified function30. A further EF-
hand containing protein in the secretory pathway is calnuc which localizes to the 
lumen of the Golgi as well as to the cytosol. Interestingly, calnuc shows some 
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similarities with MCFD2 by displaying two EF-hand motifs and being O-glycosylated 
during the secretion process31, 32.  
Although a 45Ca2+-binding assay could not determine the calcium binding 
affinity of MCFD233, both EF-hand motifs in MCFD2 are likely to be occupied due to 
the high calcium levels in the lumen of the ER.  Calcium-bound MCFD2 might display 
an ERGIC-53 binding-competent conformation while deprivation of calcium may 
induce a conformational change in MCFD2 releasing it from ERGIC-53. This 
mechanism is in agreement with findings that in vivo depletion of luminal calcium by 
thapsigargin treatment disrupts the interaction between MCFD2 and ERGIC-53. 
Thapsigargin treatment resulted in the appearance of O-glycosylated MCFD2 which 
can no longer bind to ERGIC-5328. Since thapsigargin is a strong inducer of ER 
stress by depleting luminal calcium levels and since ERGIC-53 and MCFD2 are both 
target genes of the UPR34, 35, it is tempting to speculate that ER stress can modulate 
the interaction between MCFD2 and ERGIC-53. In future experiments, it will be 
interesting to examine if there is a functional relationship between ERGIC-53, 
MCFD2 and ER stress. A further unanswered question concerns the MCFD2 binding 
site on ERGIC-53. The crystal structure of ERGIC-53 revealed a large surface patch 
of conserved residues opposite to the lectin binding site36. This surface patch could 
act as a potential MCFD2 binding site. Nuclear magnetic resonance (NMR) 
spectroscopy would be a powerful method to map the interactions interface between 
ERGIC-53 and MCFD237. In chemical shift perturbation experiments using purified 
ERGIC-53 and MCFD2, the amino acid residues involved in binding could be 
determined. To verify the NMR data, one would then mutagenize the assigned amino 
acid residues in ERGIC-53 and MCFD2 and quantify the interaction by YFP PCA in 
vivo.  
 
4.2.2 ERGIC-53/MCFD2 receptor-mediated cargo transport 
Why does secretion of blood coagulation factors V and VIII require both ERGIC-53 
and MCFD2? Depletion of MCFD2 by siRNA turned out to be a powerful approach to 
analyze the function of ERGIC-53 independent of MCFD2. Conversely, an ERGIC-53 
depletion strategy could not be used to study MCFD2 individually since MCFD2 
requires ERGIC-53 for its intracellular retention.  
As shown in this thesis, ERGIC-53 can bind cathepsin Z and cathepsin C in a 
MCFD2-independent manner. Together with the finding that blood coagulation factor 
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VIII can be crosslinked to both ERGIC-53 and MCFD228, these results lead to the 
following model of cargo selectivity of the ERGIC-53/MCFD2 complex. ERGIC-53 
can interact with cathepsin Z and cathepsin C by itself and requires MCFD2 only for 
the recruitment of blood coagulation factor V and VIII. The definitive proof of cargo 
selectivity of the ERGIC-53/MCFD2 receptor complex awaits further confirmation 
since we were unable to examine a direct interaction between ERGIC-53/MCFD2 
and blood coagulation factors V and VIII by YFP PCA. Our model derives from the 
analysis of the cargo binding properties of ERGIC-53 and needs to be complemented 
with cargo transport studies. Although ERGIC-53 binds soluble glycoproteins beyond 
any doubts, its function as transport receptor has not been proven. Evidence for 
ERGIC-53-mediated transport is strong for blood coagulation factors V and VIII and 
supported by data deriving from genetic and biochemical approaches26, 28, 38, 39. For 
cathepsin Z and cathepsin C, a delayed secretion was shown upon expression of the 
dominant-negative ER retained KKAA mutant of ERGIC-53 in cell culture40, 41. 
Evidence of a cathepsin Z and cathepsin C transport defect in ERGIC-53-deficient 
cells has not been reported yet. By analyzing the secretion of endogenous cathepsin 
C in HeLa cells after siRNA-mediated ERGIC-53 depletion, no transport defect could 
be detected (unpublished data). Since only a small fraction of cathepsin C is secreted 
while the majority is targeted to lysosomes, quantification of secreted cathepsin C 
may not be adequate to draw a reliable conclusion concerning ERGIC-53-mediated 
transport. Additionally, it can not be completely excluded that siRNA-mediated 
depletion of ERGIC-53 leaves sufficient residual protein to ensure proper cargo 
transport. This is rather unlikely, however, since the ERGIC-53 knockdown was very 
efficient and an effect on MCFD2 was readily detectable. To what extent anterograde 
transport of cathepsin Z and cathepsin C indeed depends on ERGIC-53 should be 
critically addressed in future studies. The availability of ERGIC-53 knockout mice (Bin 
Zhang, personal communication) offers new ways to address this question. It will be 
possible to determine the levels of cathepsin Z and cathepsin C in purified lysosomes 
from these mice. To address transport kinetics, cathepsin C and cathepsin Z 
transport may be analyzed in primary cell cultures derived from ERGIC-53 knockout 
mice. As control, the concentration of blood coagulation factors V and VIII can be 
readily quantified in the blood plasma of these animals and the secretion of blood 
coagulation factors can be studied in primary hepatocyte cultures42-44. Such 
experiments should definitively clarify the role of ERGIC-53 in anterograde cargo 
transport. 
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The fluorescence complementation-based cDNA library screen in this thesis 
identified alpha-1-antitrypsin as novel potential interaction partner of ERGIC-53 
suggesting that ERGIC-53 might capture more glycoproteins than initially assumed. It 
is possible that ERGIC-53 has a rather broad affinity towards glycoproteins which 
might facilitate glycoprotein secretion in general. For this purpose, it would be 
interesting to determine the carbohydrate specificity of ERGIC-53, for instance by 
frontal affinity chromatography16 or carbohydrate microarrays45.  Since other 
intracellular lectins such as VIP-3617, 18 or VIPL46, 47 might share ERGIC-53 redundant 
functions, they may compensate for a loss of ERGIC-53. The situation is different for 
blood coagulation factors V and VIII, the recruitment of which depends on the specific 
protein-protein interaction between ERGIC-53 and MCFD2. Therefore, other 
intracellular lectins might be largely unable to compensate for their secretion. This 
MCFD2 dependence would explain why the loss of ERGIC-53 has a specific effect 
on the secretion of blood coagulation factors V and VIII without affecting the 
secretion of other glycoproteins. 
How can we envisage the cargo receptor function of ERGIC-53 based on the 
currently available data? One possibility is that ERGIC-53-mediated cargo capture 
reflects a secondary quality control step. By capturing only the correctly folded 
fraction of its cargo molecules, ERGIC-53 may control the incorporation of native 
proteins into COPII-coated vesicles. Time-resolved analysis of ERGIC-53 cargo 
binding endorses a secondary quality control mechanism by showing that the 
interaction between ERGIC-53 and cathepsin Z is maximal after an initial lag-period 
which is paralleled by folding of cathepsin Z41.  To interact with ERGIC-53, cathepsin 
Z requires a folded β-hairpin/oligosaccharide structure including an intracellular 
disulfide bridge. This indicates that ERGIC-53 binds a native conformation of 
cathepsin Z. As a further possibility, ERGIC-53 might capture cargo proteins to 
facilitate their oligomerization. Recently, ERGIC-53 was reported to be involved in the 
formation of Russell bodies which are dilated ER membranes containing aggregated 
immunoglobin heavy chains48, 49. In the absence of light chains, mutant Ig-μ heavy 
chains were shown to interact with ERGIC-53 and condense into aggregates. 
Hexamerization of ERGIC-53 was speculated to seed this condensation and 
aggregation process. In more general terms, ERGIC-53 monomers may capture 
cargo molecules and by hexamerization promote the oligomerization of bound cargo 
proteins. While the oligomeric state of cathepsin Z is unknown, cathepsin C exists as 
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a tetramer and oligomerization was suggested to occur before its transport into 
lysosomes50. The analysis of the oligomerization process of cathepsin C in ERGIC-
53-depleted cells might reveal if ERGIC-53 is required for cargo protein 
oligomerization. 
In summary, the function of ERGIC-53 is still not entirely known. Nevertheless, 
the characterization of the cargo selectivity of the ERGIC-53/MCFD2 protein complex 
and the development of the luminal YFP PCA offer promising perspectives to 
address this issue. By analyzing ERGIC-53 knockout mice, by determining the 
carbohydrate-specificity of ERGIC-53, and by identifying additional ERGIC-53 
interaction partners in the genomewide YFP PCA-based protein interaction screen, 
novel functional insights may arise. 
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